Healthcare Analytical Testing Services Market - Global Forecast To 2030
商品番号 : SMB-7570
| 出版社 | MarketsandMarkets |
| 出版年月 | 2025年7月 |
| ページ数 | 436 |
| 図表数 | 507 |
| 価格タイプ | シングルユーザライセンス |
| 価格 | USD 4,950 |
本レポートは、ヘルスケア分析検査サービス市場を、種類、エンドユーザー、地域別に分析しています。市場成長に影響を与える要因、市場における様々な機会と課題の分析、そして市場リーダーの競争環境の詳細を提供しています。さらに、マイクロマーケットを個々の成長傾向に基づいて分析し、5つの主要地域（および各地域に属する国）における市場セグメントの収益予測も提供しています。
The global healthcare analytical testing services market is projected to grow from USD 7.48 billion in 2025 to USD 12.48 billion by 2030, at a CAGR of 10.8% during the forecast period. The growing demand for quality assurance and compliance across industries, improvements in analytical techniques, and support from the government for investment and innovation are major factors anticipated to boost market growth. Additionally, the demand for customized testing solutions in new markets and the evolution in the regulatory environment are factors that contribute enormously to the increase in demand for analytical testing services.
世界のヘルスケア分析検査サービス市場は、2025年の74億8,000万米ドルから2030年には124億8,000万米ドルに拡大し、予測期間中は年平均成長率（CAGR）10.8%で成長すると予測されています。業界全体における品質保証とコンプライアンスへの需要の高まり、分析技術の向上、そして政府による投資とイノベーションへの支援は、市場の成長を後押しする主な要因として期待されています。さらに、新規市場におけるカスタマイズされた検査ソリューションの需要と規制環境の変化も、分析検査サービスの需要増加に大きく貢献しています。
By type, the bioanalytical testing services segment accounted for the largest share of the market in 2024.
Based on type, the healthcare analytical testing services market is segmented into physical characterization services, method development & validation services, stability testing services, bioanalytical testing services, batch-release testing services, raw material testing services, microbial testing services, genomic testing services, environmental monitoring services, and other analytical testing services. The bioanalytical testing services segment is further segmented into immunogenicity & neutralizing antibody testing, pharmacokinetic & toxicokinetic testing, biomarker testing, bioassay testing, and other bioanalytical testing services. The increasing R&D expenditure by biotechnology & pharmaceutical companies and the growing demand for biopharmaceuticals are expected to boost market growth in the study period.
By end user, the pharmaceutical companies segment accounted for the largest market share in 2024.
By end user, the market is segmented into pharmaceutical companies, biopharmaceutical companies, medical device companies, hospitals & clinics, forensic labs, cosmetic & nutraceutical companies, and other end users. The pharmaceutical companies segment accounted for the largest share of the market in 2024. The growth of this segment can be attributed to the increasing R&D expenditure of pharma & biopharma companies and the growing number of drug discovery & clinical trial projects.
The Asia Pacific region is expected to register the highest growth rate during the forecast period.
By region, the healthcare analytical testing services market covers North America, Europe, the Asia Pacific, Latin America, and the Middle East & Africa. The Asia Pacific market is estimated to register the highest growth rate during the forecast period. The increasing outsourcing of drug discovery & development activities to emerging economies and the rising growth in the biopharmaceutical industry are expected to fuel growth in this region during the forecast period.
A breakdown of the primary participants referred to for this report is provided below:
- By Company Type: Tier 1 (45%), Tier 2 (30%), and Tier 3 (25%)
- By Designation: Directors (42%), Managers (31%), and Others (27%)
- By Region: North America (32%), Europe (32%), Asia Pacific (26%), Latin America (6%), Middle East & Africa (4%)
The prominent players in the healthcare analytical testing services market are Eurofins Scientific SE (Luxembourg), LabCorp Holdings Inc. (US), WuXi AppTec (China), Charles River Laboratories (US), SGS SA (Switzerland), Thermo Fisher Scientific Inc. (US), Medpace Holdings, Inc. (US), Sartorius AG (Germany), Intertek Group Plc (UK), Merck KGaA (Germany), SourceBio International Limited (UK), ICON Plc (Ireland), ALS (Australia), Frontage Labs (US), STERIS Plc (US), IQVIA (US), Element Materials Technology (UK), Pace Analytical Services (US), Almac Group (UK), and Pharmaron Beijing Co., Ltd. (China), among others.
Research Coverage
This report studies the healthcare analytical testing services market based on type, end user, and region. It also covers the factors affecting market growth, analyzes the various opportunities and challenges in the market, and provides details of the competitive landscape for market leaders. Furthermore, the report analyzes micromarkets with respect to their individual growth trends and forecasts the revenue of the market segments with respect to five main regions (and the respective countries in these regions).
Reasons to Buy the Report
The report will help both established companies and newcomers/smaller businesses understand the market dynamics, enabling them to increase their market share. Companies that purchase the report can use one or a combination of the strategies listed below to enhance their market presence.
This report provides insights on the following pointers:
- Analysis of key drivers (stringent regulatory guidelines, growing focus on analytical testing of biologics & biosimilars, increasing outsourcing of analytical testing by pharmaceutical & medical device companies, increasing number of clinical trials, growing R&D expenditure in pharmaceutical & biopharmaceutical industry, and rising acceptance of quality-by-design approach in pharmaceutical research & manufacturing), restraints (increasing pressure on market players due to rising costs and market competition), opportunities (adoption of new techniques and technologies and growing focus on emerging economies), and challenges (shortage of skilled professionals, specific requirements for innovative formulations and medical devices, and need to improve sensitivity of bioanalytical methods) influencing the growth of the healthcare analytical testing services market.
- Market Penetration: Comprehensive information on the product portfolios offered by the top players in the healthcare analytical testing services market.
- Analytical Development/Innovation: Detailed insights on the upcoming trends, R&D activities, and developments in the healthcare analytical testing services market.
- Market Development: Comprehensive information on lucrative emerging regions.
- Market Diversification: Exhaustive information about new services, growing geographies, and recent developments in the healthcare analytical testing services market.
- Competitive Assessment: In-depth assessment of market segments, growth strategies, revenue analysis, and services of the leading market players.
Table of Contents
1 INTRODUCTION 38
1.1 STUDY OBJECTIVES 38
1.2 MARKET DEFINITION 38
1.3 MARKET SCOPE 39
1.3.1 MARKETS & REGIONS COVERED 39
1.3.2 REGIONS COVERED 40
1.3.3 INCLUSIONS & EXCLUSIONS 40
1.3.4 YEARS CONSIDERED 41
1.3.5 CURRENCY CONSIDERED 41
1.4 LIMITATIONS 41
1.4.1 METHODOLOGY-RELATED LIMITATIONS 42
1.4.2 SCOPE-RELATED LIMITATIONS 42
1.5 MARKET STAKEHOLDERS 42
1.6 SUMMARY OF CHANGES 43
2 RESEARCH METHODOLOGY 44
2.1 RESEARCH DATA 44
2.2 RESEARCH METHODOLOGY STEPS 44
2.2.1 SECONDARY DATA 45
2.2.1.1 List of secondary sources 46
2.2.1.2 Key data from secondary sources 47
2.2.2 PRIMARY DATA 47
2.2.2.1 Key data from primary sources 48
2.2.2.2 Insights from primary experts 49
2.3 MARKET ESTIMATION METHODOLOGY 50
2.3.1 PRIMARY RESEARCH VALIDATION 57
2.4 DATA TRIANGULATION AND MARKET BREAKDOWN 58
2.5 RESEARCH ASSUMPTIONS 59
2.5.1 STUDY ASSUMPTIONS 59
2.6 RESEARCH LIMITATIONS 60
2.7 RISK ASSESSMENT 60
3 EXECUTIVE SUMMARY 61
4 PREMIUM INSIGHTS 66
4.1 HEALTHCARE ANALYTICAL TESTING SERVICES MARKET OVERVIEW 66
4.2 EUROPE: HEALTHCARE ANALYTICAL TESTING SERVICES MARKET, BY TYPE & COUNTRY (2024) 67
4.3 HEALTHCARE ANALYTICAL TESTING SERVICES MARKET: GEOGRAPHIC GROWTH OPPORTUNITIES 68
4.4 HEALTHCARE ANALYTICAL TESTING SERVICES MARKET: REGIONAL MIX,
2023–2030 (USD MILLION) 69
5 MARKET OVERVIEW 70
5.1 INTRODUCTION 70
5.2 MARKET DYNAMICS 70
5.2.1 DRIVERS 71
5.2.1.1 Stringent regulatory guidelines 71
5.2.1.2 Growing focus on analytical testing of biologics & biosimilars 72
5.2.1.3 Increasing outsourcing of analytical testing services by pharmaceutical & medical device companies 73
5.2.1.4 Rising number of clinical trials 73
5.2.1.5 Growing R&D expenditure in pharmaceutical & biopharmaceutical industry 74
5.2.1.6 Rising acceptance of quality-by-design approach in pharmaceutical research & manufacturing 75
5.2.2 RESTRAINTS 76
5.2.2.1 Increasing pressure on market players due to rising costs and market competition 76
5.2.3 OPPORTUNITIES 77
5.2.3.1 Adoption of new techniques and technologies 77
5.2.3.2 Growing focus on emerging economies 78
5.2.4 CHALLENGES 79
5.2.4.1 Shortage of skilled professionals 79
5.2.4.2 Specific requirements for innovative formulations and medical devices 79
5.2.4.3 Challenges associated with ensuring bioanalytical testing sensitivity 80
5.3 ECOSYSTEM ANALYSIS 80
5.4 REGULATORY SCENARIO 82
5.4.1 REGULATORY BODIES, GOVERNMENT AGENCIES AND OTHER ORGANIZATIONS 82
5.4.2 REGULATORY TRENDS 84
5.4.3 NORTH AMERICA 86
5.4.4 EUROPE 86
5.4.5 ASIA PACIFIC 87
5.5 VALUE CHAIN ANALYSIS 88
5.5.1 SAMPLE MANAGEMENT & PREPARATION 88
5.5.2 ANALYTICAL TESTING PROCEDURES 88
5.5.3 DATA ANALYTICS & INTEGRATION 88
5.5.4 QUALITY ASSURANCE & CONTROL 88
5.5.5 CLIENT COMMUNICATION & SERVICE DELIVERY 89
5.6 CASE STUDY ANALYSIS 89
5.6.1 CASE STUDY 1: UNLOCKING POTENTIAL OF BIOPHARMACEUTICAL DEVELOPMENT THROUGH ANALYTICAL TESTING OUTSOURCING 89
5.6.2 CASE STUDY 2: REVOLUTIONIZING PHARMACEUTICAL TESTING 90
5.7 PORTER’S FIVE FORCES ANALYSIS 90
5.7.1 THREAT OF NEW ENTRANTS 91
5.7.2 BARGAINING POWER OF SUPPLIERS 92
5.7.3 INTENSITY OF COMPETITIVE RIVALRY 92
5.7.4 BARGAINING POWER OF BUYERS 92
5.7.5 THREAT OF SUBSTITUTES 92
5.8 KEY STAKEHOLDERS & BUYING CRITERIA 93
5.8.1 KEY STAKEHOLDERS IN BUYING PROCESS 93
5.8.2 KEY BUYING CRITERIA 94
5.9 TECHNOLOGY ANALYSIS 95
5.9.1 KEY TECHNOLOGIES 95
5.9.1.1 Chromatography 95
5.9.1.2 Mass spectrometry (MS) 95
5.9.1.3 Spectroscopy 96
5.9.2 COMPLEMENTARY TECHNOLOGIES 96
5.9.2.1 Laboratory Information Management Systems (LIMS) 96
5.9.2.2 Automation & robotics 96
5.9.2.3 AI/ML in data analytics 96
5.9.3 ADJACENT TECHNOLOGIES 97
5.9.3.1 Single-use bioreactors 97
5.9.3.2 mRNA technology 97
5.9.3.3 Next-generation Sequencing (NGS) 97
5.10 KEY CONFERENCES & EVENTS, 2024─2025 98
5.11 TRENDS/DISRUPTIONS IMPACTING CUSTOMERS’ BUSINESSES 99
5.12 INVESTMENT & FUNDING SCENARIO 99
5.13 UNMET NEEDS/END-USER EXPECTATIONS 101
5.14 IMPACT OF AI/GENERATIVE AI ON HEALTHCARE ANALYTICAL TESTING SERVICES MARKET 102
5.15 TRUMP TARIFF IMPACT ON HEALTHCARE ANALYTICAL TESTING MARKET 103
5.15.1 INTRODUCTION 103
5.15.2 KEY TARIFF RATES 105
5.15.3 PRICE IMPACT ANALYSIS 106
5.15.4 KEY IMPACT ON VARIOUS REGIONS 107
5.15.4.1 North America 107
5.15.4.2 Europe 107
5.15.4.3 Asia Pacific 108
6 HEALTHCARE ANALYTICAL TESTING SERVICES MARKET, BY TYPE 109
6.1 INTRODUCTION 110
6.2 BIOANALYTICAL TESTING SERVICES 110
6.2.1 PHARMACOKINETIC & TOXICOKINETIC TESTING SERVICES 112
6.2.1.1 Essential role in drug individualized dosing and therapeutic monitoring to drive market 112
6.2.2 IMMUNOGENICITY & NEUTRALIZING ANTIBODY TESTING SERVICES 113
6.2.2.1 Increasing requirement for drug safety approvals to fuel uptake 113
6.2.3 BIOMARKER TESTING SERVICES SERVICES 114
6.2.3.1 Growing preference for personalized medicine to fuel market 114
6.2.4 BIOASSAY TESTING SERVICES 115
6.2.4.1 Growing adoption of high-content screening for cytotoxicity testing to boost demand 115
6.2.5 OTHER BIOANALYTICAL TESTING SERVICES 116
6.3 PHYSICAL CHARACTERIZATION SERVICES 117
6.3.1 LASER PARTICLE SIZE ANALYSIS SERVICES 118
6.3.1.1 Growing importance of pharmaceutical dosage manufacturing to drive market 118
6.3.2 THERMAL ANALYSIS SERVICES 119
6.3.2.1 Advancements in thermal analysis techniques to support market growth 119
6.3.3 OPTICAL CHARACTERIZATION SERVICES 120
6.3.3.1 Increasing complexities of biological structures to boost demand 120
6.3.4 SURFACE AREA ANALYSIS SERVICES 121
6.3.4.1 Growing focus on streamlining drug development processes to fuel uptake 121
6.3.5 OTHER PHYSICAL CHARACTERIZATION SERVICES 122
6.4 METHOD DEVELOPMENT & VALIDATION SERVICES 123
6.4.1 EXTRACTABLES/LEACHABLES METHOD DEVELOPMENT & VALIDATION SERVICES 125
6.4.1.1 Adoption of parenterally administered drugs and biologics products to drive market 125
6.4.2 PROCESS IMPURITY METHOD DEVELOPMENT & VALIDATION SERVICES 126
6.4.2.1 Increasing emphasis on impurity testing to boost market 126
6.4.3 STABILITY-INDICATING METHOD VALIDATION SERVICES 127
6.4.3.1 Growing need to ensure safety & efficacy of drugs to drive market 127
6.4.4 CLEANING VALIDATION & METHOD DEVELOPMENT SERVICES 127
6.4.4.1 Focus on contamination reduction to fuel market 127
6.4.5 ANALYTICAL STANDARD CHARACTERIZATION SERVICES 128
6.4.5.1 Assessment of quantitative & qualitative accuracy to fuel uptake 128
6.4.6 TECHNICAL CONSULTING SERVICES 129
6.4.6.1 Stringent regulatory compliance to boost demand 129
6.4.7 OTHER METHOD DEVELOPMENT & VALIDATION SERVICES 130
6.5 RAW MATERIAL TESTING SERVICES 131
6.5.1 COMPLETE COMPENDIAL TESTING SERVICES 132
6.5.1.1 Need to determine efficacy & safety of therapeutic products to drive market 132
6.5.2 CONTAINER TESTING SERVICES 133
6.5.2.1 Optimization of sealing & evaluation of temperature impact to fuel uptake 133
6.5.3 HEAVY METAL TESTING SERVICES 134
6.5.3.1 Uptake of specialized equipment to support market growth 134
6.5.4 WATER CONTENT ANALYSIS SERVICES 135
6.5.4.1 Adequate moisture content analysis to fuel market 135
6.5.5 OTHER RAW MATERIAL TESTING SERVICES 136
6.6 BATCH-RELEASE TESTING SERVICES 137
6.6.1 DISSOLUTION TESTING SERVICES 138
6.6.1.1 Wide usage across formulation development & manufacturing applications to drive market 138
6.6.2 ELEMENTAL IMPURITY TESTING SERVICES 139
6.6.2.1 Rising need to minimize cost of in-house analysis to fuel market 139
6.6.3 DISINTEGRATION TESTING SERVICES 140
6.6.3.1 Ability to ensure batch-to-batch consistency of pharmaceutical dosage forms to fuel market 140
6.6.4 HARDNESS TESTING SERVICES 142
6.6.4.1 Measurement of tablet quality to support market growth 142
6.6.5 FRIABILITY TESTING SERVICES 143
6.6.5.1 Resistance measurement of tablets & granules to fuel market 143
6.6.6 OTHER BATCH-RELEASE TESTING SERVICES 143
6.7 STABILITY TESTING SERVICES 144
6.7.1 DRUG SUBSTANCE STABILITY TESTING SERVICES 145
6.7.1.1 Evidence testing on quality of pharmaceutical stability to fuel market 145
6.7.2 FORMULATION EVALUATION STABILITY TESTING SERVICES 146
6.7.2.1 Analysis of shelf life to fuel adoption 146
6.7.3 ACCELERATED STABILITY TESTING SERVICES 147
6.7.3.1 High stress conditions to provide enhanced results 147
6.7.4 PHOTOSTABILITY TESTING SERVICES 148
6.7.4.1 Systemic approach for ICH guideline adherence to propel market 148
6.7.5 FORCED DEGRADATION TESTING SERVICES 149
6.7.5.1 Rising need for comprehensive stability testing to drive market 149
6.7.6 OTHER STABILITY TESTING SERVICES 150
6.8 MICROBIAL TESTING SERVICES 150
6.8.1 MICROBIAL LIMIT TESTING SERVICES 151
6.8.1.1 Microbial quality efficacy testing to boost demand 151
6.8.2 VIROLOGY TESTING SERVICES 153
6.8.2.1 Increasing outbreaks of viral diseases to drive market 153
6.8.3 STERILITY TESTING SERVICES 154
6.8.3.1 Rising development of parenteral preparations and immunological products to drive market 154
6.8.4 ENDOTOXIN TESTING SERVICES 155
6.8.4.1 Endoxin-free testing to fuel market 155
6.8.5 PRESERVATIVE EFFICACY TESTING SERVICES 156
6.8.5.1 PET testing for toxicity to fuel uptake 156
6.8.6 OTHER MICROBIAL TESTING SERVICES 156
6.9 ENVIRONMENTAL MONITORING SERVICES 157
6.9.1 AIR TESTING SERVICES 158
6.9.1.1 Air contamination testing for quality checks to fuel market 158
6.9.2 WASTEWATER/ETP TESTING SERVICES 160
6.9.2.1 Need to minimize water contamination to fuel market 160
6.9.3 OTHER ENVIRONMENTAL MONITORING TESTING SERVICES 161
6.10 GENOMIC TESTING SERVICES 162
6.10.1 DETECTION OF DISEASE MECHANISMS AND TREATMENT RESPONSES TO PROPEL MARKET 162
6.11 OTHER ANALYTICAL TESTING SERVICES 163
7 HEALTHCARE ANALYTICAL TESTING SERVICES MARKET, BY END USER 164
7.1 INTRODUCTION 165
7.2 PHARMACEUTICAL COMPANIES 165
7.2.1 GROWTH IN PHARMACEUTICAL INDUSTRY TO PROPEL MARKET 165
7.3 BIOPHARMACEUTICAL COMPANIES 167
7.3.1 INCREASING R&D INVESTMENTS TO FUEL MARKET 167
7.4 MEDICAL DEVICE COMPANIES 168
7.4.1 STRINGENT PRODUCT COMMERCIALIZATION GUIDELINES TO DRIVE MARKET 168
7.5 HOSPITALS & CLINICS 169
7.5.1 INCREASING INCIDENCE OF CHRONIC DISEASES TO BOOST DEMAND 169
7.6 FORENSIC LABS 170
7.6.1 RISING UTILIZATION OF ANALYTICAL TESTING TO FUEL MARKET 170
7.7 COSMETIC & NUTRACEUTICAL COMPANIES 171
7.7.1 RISING FOCUS ON QUALITY CONTROL TESTING TO FUEL UPTAKE 171
7.8 OTHER END USERS 172
8 HEALTHCARE ANALYTICAL TESTING MARKET, BY REGION 174
8.1 INTRODUCTION 175
8.2 NORTH AMERICA 175
8.2.1 MACROECONOMIC OUTLOOK FOR NORTH AMERICA 176
8.2.2 US 183
8.2.2.1 High number of pre-registration drugs in pipeline to drive market 183
8.2.3 CANADA 188
8.2.3.1 Presence of well-established CROs to support market growth 188
8.3 EUROPE 193
8.3.1 MACROECONOMIC OUTLOOK FOR EUROPE 194
8.3.2 GERMANY 199
8.3.2.1 Government support and flexible labor laws to boost demand 199
8.3.3 FRANCE 205
8.3.3.1 Favorable government regulations to drive market 205
8.3.4 UK 210
8.3.4.1 Increasing outsourcing of biopharmaceutical R&D to drive market 210
8.3.5 ITALY 215
8.3.5.1 Availability of drug discovery funding investments to fuel market 215
8.3.6 SWITZERLAND 220
8.3.6.1 High production of pharma drugs to fuel uptake 220
8.3.7 SPAIN 225
8.3.7.1 Rising number of clinical trials to boost demand 225
8.3.8 REST OF EUROPE 230
8.4 ASIA PACIFIC 235
8.4.1 MACROECONOMIC OUTLOOK FOR ASIA PACIFIC 236
8.4.2 JAPAN 243
8.4.2.1 Expanding geriatric population and increasing incidence of chronic diseases to propel market 243
8.4.3 CHINA 248
8.4.3.1 Increasing incidence of infectious diseases to boost demand 248
8.4.4 INDIA 253
8.4.4.1 Growing focus on establishment of genomic testing centers to drive market 253
8.4.5 AUSTRALIA 258
8.4.5.1 Large number of research institutes to support market uptake 258
8.4.6 SOUTH KOREA 263
8.4.6.1 Launch of innovative pharma drugs to boost demand 263
8.4.7 REST OF ASIA PACIFIC 268
8.5 LATIN AMERICA 273
8.5.1 MACROECONOMIC OUTLOOK FOR LATIN AMERICA 273
8.5.2 BRAZIL 279
8.5.2.1 Rising adoption of emerging medical technologies to drive market 279
8.5.3 MEXICO 284
8.5.3.1 Favorable regulatory environment for API products to fuel market 284
8.5.4 REST OF LATIN AMERICA 289
8.6 MIDDLE EAST & AFRICA 294
8.6.1 MACROECONOMIC OUTLOOK FOR MIDDLE EAST & AFRICA 295
8.6.2 GCC COUNTRIES 300
8.6.2.1 Improvements in healthcare infrastructure to boost demand 300
8.6.3 REST OF MIDDLE EAST & AFRICA 305
9 COMPETITIVE LANDSCAPE 310
9.1 OVERVIEW 310
9.2 KEY PLAYER STRATEGIES/RIGHT TO WIN 310
9.2.1 OVERVIEW OF STRATEGIES ADOPTED BY KEY PLAYERS IN HEALTHCARE ANALYTICAL TESTING SERVICES MARKET 310
9.3 REVENUE ANALYSIS, 2020−2024 312
9.4 MARKET SHARE ANALYSIS, 2024 313
9.5 COMPANY EVALUATION MATRIX: KEY PLAYERS, 2024 315
9.5.1 STARS 316
9.5.2 EMERGING LEADERS 316
9.5.3 PERVASIVE PLAYERS 316
9.5.4 PARTICIPANTS 316
9.5.5 COMPANY FOOTPRINT: KEY PLAYERS, 2024 318
9.5.5.1 Company footprint 318
9.5.5.2 Region footprint 319
9.5.5.3 Type footprint 320
9.5.5.4 End-user footprint 321
9.6 COMPANY EVALUATION MATRIX: STARTUPS/SMES, 2024 322
9.6.1 PROGRESSIVE COMPANIES 322
9.6.2 RESPONSIVE COMPANIES 322
9.6.3 DYNAMIC COMPANIES 322
9.6.4 STARTING BLOCKS 322
9.6.5 COMPETITIVE BENCHMARKING: STARTUPS/SMES, 2024 324
9.6.5.1 Detailed list of startups/SMEs 324
9.6.5.2 Competitive benchmarking of emerging players/startups 325
9.7 COMPANY VALUATION & FINANCIAL METRICS 327
9.7.1 FINANCIAL METRICS 327
9.7.2 COMPANY VALUATION 327
9.8 BRAND/SERVICE COMPARISON 328
9.8.1 BRAND/SERVICE COMPARATIVE ANALYSIS 328
9.9 COMPETITIVE SCENARIO 329
9.9.1 SERVICE LAUNCHES 329
9.9.2 DEALS 330
9.9.3 EXPANSIONS 331
10 COMPANY PROFILES 333
10.1 KEY PLAYERS 333
10.1.1 EUROFINS SCIENTIFIC SE 333
10.1.1.1 Business overview 333
10.1.1.2 Services offered 334
10.1.1.3 Recent developments 336
10.1.1.3.1 Deals 336
10.1.1.3.2 Expansions 337
10.1.1.4 MnM view 337
10.1.1.4.1 Key strengths 337
10.1.1.4.2 Strategic choices 338
10.1.1.4.3 Weaknesses & competitive threats 338
10.1.2 LABCORP HOLDINGS INC. 339
10.1.2.1 Business overview 339
10.1.2.2 Services offered 340
10.1.2.3 Recent developments 341
10.1.2.3.1 Services launches 341
10.1.2.3.2 Deals 341
10.1.2.3.3 Expansions 342
10.1.2.4 MnM view 343
10.1.2.4.1 Key strengths 343
10.1.2.4.2 Strategic choices 343
10.1.2.4.3 Weaknesses & competitive threats 343
10.1.3 INTERTEK GROUP PLC 344
10.1.3.1 Business overview 344
10.1.3.2 Services offered 345
10.1.3.3 Recent developments 349
10.1.3.3.1 Deals 349
10.1.3.3.2 Expansions 349
10.1.3.4 MnM view 350
10.1.3.4.1 Key strengths 350
10.1.3.4.2 Strategic choices 350
10.1.3.4.3 Weaknesses & competitive threats 350
10.1.4 ICON PLC 351
10.1.4.1 Business overview 351
10.1.4.2 Services offered 352
10.1.4.3 Recent developments 353
10.1.4.3.1 Deals 353
10.1.4.4 MnM view 354
10.1.4.4.1 Key strengths 354
10.1.4.4.2 Strategic choices 354
10.1.4.4.3 Weaknesses & competitive threats 354
10.1.5 IQVIA INC. 355
10.1.5.1 Business overview 355
10.1.5.2 Services offered 356
10.1.5.3 Recent developments 357
10.1.5.3.1 Expansions 357
10.1.5.3.2 Other developments 358
10.1.5.4 MnM view 358
10.1.5.4.1 Key strengths 358
10.1.5.4.2 Strategic choices 358
10.1.5.4.3 Weaknesses & competitive threats 358
10.1.6 WUXI APPTEC CO., LTD. 359
10.1.6.1 Business overview 359
10.1.6.2 Services offered 360
10.1.6.3 Recent developments 361
10.1.6.3.1 Service launches 361
10.1.6.3.2 Deals 362
10.1.6.3.3 Expansions 362
10.1.7 CHARLES RIVER LABORATORIES 363
10.1.7.1 Business overview 363
10.1.7.2 Services offered 364
10.1.7.3 Recent developments 365
10.1.7.3.1 Service launches & approvals 365
10.1.7.3.2 Deals 366
10.1.7.3.3 Expansions 367
10.1.8 SGS SA 368
10.1.8.1 Business overview 368
10.1.8.2 Services offered 369
10.1.8.3 Recent developments 371
10.1.8.3.1 Service launches 371
10.1.8.3.2 Deals 371
10.1.8.3.3 Expansions 372
10.1.8.3.4 Other developments 373
10.1.9 THERMO FISHER SCIENTIFIC INC. 374
10.1.9.1 Business overview 374
10.1.9.2 Services offered 375
10.1.9.3 Recent developments 376
10.1.9.3.1 Deals 376
10.1.9.3.2 Expansions 377
10.1.10 MEDPACE HOLDINGS, INC. 378
10.1.10.1 Business overview 378
10.1.10.2 Services offered 379
10.1.10.3 Recent developments 380
10.1.10.3.1 Deals 380
10.1.10.3.2 Expansions 380
10.1.11 SARTORIUS AG 381
10.1.11.1 Business overview 381
10.1.11.2 Services offered 382
10.1.11.3 Recent developments 383
10.1.11.3.1 Deals 383
10.1.11.3.2 Expansions 383
10.1.12 MERCK KGAA 384
10.1.12.1 Business overview 384
10.1.12.2 Services offered 385
10.1.12.3 Recent developments 386
10.1.12.3.1 Service launches 386
10.1.12.3.2 Deals 386
10.1.12.3.3 Expansions 387
10.1.12.3.4 Other developments 387
10.1.13 SOURCE BIOSCIENCE (SUBSIDIARY OF SOURCEBIO INTERNATIONAL PLC) 389
10.1.13.1 Business overview 389
10.1.13.2 Services offered 390
10.1.13.3 Recent developments 390
10.1.13.3.1 Service launches 390
10.1.13.3.2 Expansions 391
10.1.14 ALS 392
10.1.14.1 Business overview 392
10.1.14.2 Services offered 393
10.1.14.3 Recent developments 394
10.1.14.3.1 Deals 394
10.1.15 FRONTAGE LABORATORIES, INC. 395
10.1.15.1 Business overview 395
10.1.15.2 Services offered 396
10.1.15.3 Recent developments 398
10.1.15.3.1 Deals 398
10.1.15.3.2 Expansions 398
10.1.16 STERIS PLC 399
10.1.16.1 Business overview 399
10.1.16.2 Services offered 400
10.1.16.3 Recent developments 401
10.1.16.3.1 Service launches 401
10.1.16.3.2 Expansions 401
10.1.16.3.3 Other developments 402
10.1.17 ELEMENT MATERIALS TECHNOLOGY 403
10.1.17.1 Business overview 403
10.1.17.2 Services offered 403
10.1.17.3 Recent developments 404
10.1.17.3.1 Service launches 404
10.1.17.3.2 Deals 404
10.1.17.3.3 Expansions 405
10.1.17.3.4 Other developments 406
10.1.18 PACE ANALYTICAL SERVICES 407
10.1.18.1 Business overview 407
10.1.18.2 Services offered 407
10.1.18.3 Recent developments 409
10.1.18.3.1 Deals 409
10.1.18.3.2 Expansions 411
10.1.19 ALMAC GROUP 412
10.1.19.1 Business overview 412
10.1.19.2 Services offered 412
10.1.19.3 Recent developments 413
10.1.19.3.1 Service approvals 413
10.1.19.3.2 Deals 413
10.1.19.3.3 Expansions 413
10.1.20 PHARMARON BEIJING CO., LTD. 415
10.1.20.1 Business overview 415
10.1.20.2 Services offered 415
10.1.20.3 Recent developments 416
10.1.20.3.1 Deals 416
10.2 OTHER PLAYERS 417
10.2.1 SYNEOS HEALTH 417
10.2.2 PAREXEL INTERNATIONAL (MA) CORPORATION 418
10.2.3 LGC LIMITED 419
10.2.4 CELERION 420
10.2.5 BIOAGILYTIX 421
10.2.6 ALCAMI CORPORATION 422
10.2.7 SAMSUNG BIOLOGICS 423
10.2.8 CURIA GLOBAL, INC. 424
10.2.9 BA SCIENCES 425
10.2.10 AVANCE BIOSCIENCES 426
11 APPENDIX 427
11.1 DISCUSSION GUIDE 427
11.2 KNOWLEDGESTORE: MARKETSANDMARKETS’ SUBSCRIPTION PORTAL 432
11.3 CUSTOMIZATION OPTIONS 434
11.4 RELATED REPORTS 434
11.5 AUTHOR DETAILS 435
LIST OF TABLES
TABLE 1 INCLUSIONS & EXCLUSIONS 40
TABLE 2 HEALTHCARE ANALYTICAL TESTING SERVICES MARKET: RISK ASSESSMENT ANALYSIS 60
TABLE 3 PATENT EXPIRY OF BEST-SELLING BIOLOGICS 72
TABLE 4 IMPACT ANALYSIS: DRIVERS 76
TABLE 5 IMPACT ANALYSIS: RESTRAINTS 77
TABLE 6 IMPACT ANALYSIS: OPPORTUNITIES 78
TABLE 7 IMPACT ANALYSIS: CHALLENGES 80
TABLE 8 HEALTHCARE ANALYTICAL TESTING SERVICES MARKET: ROLE IN ECOSYSTEM 81
TABLE 9 NORTH AMERICA: LIST OF REGULATORY BODIES, GOVERNMENT AGENCIES,
AND OTHER ORGANIZATIONS 82
TABLE 10 EUROPE: LIST OF REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS 82
TABLE 11 ASIA PACIFIC: LIST OF REGULATORY BODIES, GOVERNMENT AGENCIES,
AND OTHER ORGANIZATIONS 83
TABLE 12 LATIN AMERICA: LIST OF REGULATORY BODIES, GOVERNMENT AGENCIES,
AND OTHER ORGANIZATIONS 83
TABLE 13 MIDDLE EAST & AFRICA: LIST OF REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS 83
TABLE 14 ICH QUALITY GUIDELINES FOR PHARMACEUTICAL GMPS 84
TABLE 15 OVERVIEW OF GUIDELINES OF LABORATORY SERVICES 85
TABLE 16 DEVELOPMENT OF GLP ACROSS COUNTRIES 86
TABLE 17 REGULATORY AUTHORITIES AND LAUNCH OF GLP MONITORING PROGRAMS IN EUROPEAN COUNTRIES 87
TABLE 18 HEALTHCARE ANALYTICAL TESTING SERVICES MARKET: PORTER’S FIVE FORCES ANALYSIS 90
TABLE 19 INFLUENCE OF STAKEHOLDERS ON BUYING PROCESS FOR END USERS 94
TABLE 20 KEY BUYING CRITERIA FOR HEALTHCARE ANALYTICAL TESTING SERVICES,
BY RANK 95
TABLE 21 HEALTHCARE ANALYTICAL TESTING SERVICES MARKET: DETAILED LIST OF LEADING CONFERENCES & EVENTS 98
TABLE 22 HEALTHCARE ANALYTICAL TESTING SERVICES MARKET: CURRENT UNMET NEEDS/END-USER EXPECTATIONS 101
TABLE 23 US-ADJUSTED RECIPROCAL TARIFF RATES 105
TABLE 24 HEALTHCARE ANALYTICAL TESTING SERVICES MARKET, BY TYPE,
2023–2030 (USD MILLION) 110
TABLE 25 BIOANALYTICAL TESTING SERVICES MARKET, BY TYPE, 2023–2030 (USD MILLION) 111
TABLE 26 BIOANALYTICAL TESTING SERVICES MARKET, BY REGION,
2023–2030 (USD MILLION) 111
TABLE 27 PHARMACOKINETIC & TOXICOKINETIC TESTING SERVICES MARKET, BY REGION 112
TABLE 28 IMMUNOGENICITY & NEUTRALIZING ANTIBODY TESTING SERVICES MARKET,
BY REGION, 2023–2030 (USD MILLION) 114
TABLE 29 BIOMARKER TESTING SERVICES MARKET, BY REGION, 2023–2030 (USD MILLION) 115
TABLE 30 BIOASSAY TESTING SERVICES MARKET, BY REGION, 2023–2030 (USD MILLION) 116
TABLE 31 OTHER BIOANALYTICAL TESTING SERVICES MARKET, BY REGION,
2023–2030 (USD MILLION) 116
TABLE 32 PHYSICAL CHARACTERIZATION SERVICES MARKET, BY TYPE,
2023–2030 (USD MILLION) 117
TABLE 33 PHYSICAL CHARACTERIZATION SERVICES MARKET, BY REGION,
2023–2030 (USD MILLION) 118
TABLE 34 LASER PARTICLE SIZE ANALYSIS SERVICES MARKET, BY REGION,
2023–2030 (USD MILLION) 119
TABLE 35 THERMAL ANALYSIS SERVICES MARKET, BY REGION, 2023–2030 (USD MILLION) 120
TABLE 36 OPTICAL CHARACTERIZATION SERVICES MARKET, BY REGION,
2023–2030 (USD MILLION) 121
TABLE 37 SURFACE AREA ANALYSIS SERVICES MARKET, BY REGION,
2023–2030 (USD MILLION) 122
TABLE 38 OTHER PHYSICAL CHARACTERIZATION SERVICES MARKET, BY REGION,
2023–2030 (USD MILLION) 123
TABLE 39 METHOD DEVELOPMENT & VALIDATION SERVICES MARKET, BY TYPE,
2023–2030 (USD MILLION) 124
TABLE 40 METHOD DEVELOPMENT & VALIDATION SERVICES MARKET, BY REGION,
2023–2030 (USD MILLION) 124
TABLE 41 EXTRACTABLES/LEACHABLES METHOD DEVELOPMENT & VALIDATION SERVICES MARKET, BY REGION, 2023–2030 (USD MILLION) 125
TABLE 42 PROCESS IMPURITY METHOD DEVELOPMENT & VALIDATION SERVICES MARKET, BY REGION, 2023–2030 (USD MILLION) 126
TABLE 43 STABILITY-INDICATING METHOD VALIDATION SERVICES MARKET, BY REGION, 2023–2030 (USD MILLION) 127
TABLE 44 CLEANING VALIDATION & METHOD DEVELOPMENT SERVICES MARKET,
BY REGION, 2023–2030 (USD MILLION) 128
TABLE 45 ANALYTICAL STANDARD CHARACTERIZATION SERVICES MARKET,
BY REGION, 2023–2030 (USD MILLION) 129
TABLE 46 TECHNICAL CONSULTING SERVICES MARKET, BY REGION,
2023–2030 (USD MILLION) 130
TABLE 47 OTHER METHOD DEVELOPMENT & VALIDATION SERVICES MARKET,
BY REGION, 2023–2030 (USD MILLION) 131
TABLE 48 RAW MATERIAL TESTING SERVICES MARKET, BY TYPE, 2023–2030 (USD MILLION) 132
TABLE 49 RAW MATERIAL TESTING SERVICES MARKET, BY REGION,
2023–2030 (USD MILLION) 132
TABLE 50 COMPLETE COMPENDIAL TESTING SERVICES MARKET, BY REGION,
2023–2030 (USD MILLION) 133
TABLE 51 CONTAINER TESTING SERVICES MARKET, BY REGION, 2023–2030 (USD MILLION) 134
TABLE 52 HEAVY METAL TESTING SERVICES MARKET, BY REGION,
2023–2030 (USD MILLION) 135
TABLE 53 WATER CONTENT ANALYSIS SERVICES MARKET, BY REGION,
2023–2030 (USD MILLION) 136
TABLE 54 OTHER RAW MATERIAL TESTING SERVICES MARKET, BY REGION,
2023–2030 (USD MILLION) 136
TABLE 55 BATCH-RELEASE TESTING SERVICES MARKET, BY TYPE,
2023–2030 (USD MILLION) 137
TABLE 56 BATCH-RELEASE TESTING SERVICES MARKET, BY REGION,
2023–2030 (USD MILLION) 138
TABLE 57 DISSOLUTION TESTING SERVICES MARKET, BY REGION,
2023–2030 (USD MILLION) 139
TABLE 58 ELEMENTAL IMPURITY TESTING SERVICES MARKET, BY REGION,
2023–2030 (USD MILLION) 140
TABLE 59 BREAKDOWN OF DISINTEGRATION METHODS & IMMERSION MEDIA 141
TABLE 60 DISINTEGRATION TESTING SERVICES MARKET, BY REGION,
2023–2030 (USD MILLION) 141
TABLE 61 HARDNESS TESTING SERVICES MARKET, BY REGION, 2023–2030 (USD MILLION) 142
TABLE 62 FRIABILITY TESTING SERVICES MARKET, BY REGION, 2023–2030 (USD MILLION) 143
TABLE 63 OTHER BATCH-RELEASE TESTING SERVICES MARKET, BY REGION,
2023–2030 (USD MILLION) 144
TABLE 64 STABILITY TESTING SERVICES MARKET, BY TYPE, 2023–2030 (USD MILLION) 145
TABLE 65 STABILITY TESTING SERVICES MARKET, BY REGION, 2023–2030 (USD MILLION) 145
TABLE 66 DRUG SUBSTANCE STABILITY TESTING SERVICES MARKET, BY REGION,
2023–2030 (USD MILLION) 146
TABLE 67 FORMULATION EVALUATION STABILITY TESTING SERVICES MARKET,
BY REGION, 2023–2030 (USD MILLION) 147
TABLE 68 ACCELERATED STABILITY TESTING SERVICES MARKET, BY REGION,
2023–2030 (USD MILLION) 148
TABLE 69 PHOTOSTABILITY TESTING SERVICES MARKET, BY REGION,
2023–2030 (USD MILLION) 149
TABLE 70 FORCED DEGRADATION TESTING SERVICES MARKET, BY REGION,
2023–2030 (USD MILLION) 149
TABLE 71 OTHER STABILITY TESTING SERVICES MARKET, BY REGION,
2023–2030 (USD MILLION) 150
TABLE 72 MICROBIAL TESTING SERVICES MARKET, BY TYPE, 2023–2030 (USD MILLION) 151
TABLE 73 MICROBIAL TESTING SERVICES MARKET, BY REGION, 2023–2030 (USD MILLION) 151
TABLE 74 STANDARD LIMITS FOR MICROBIAL LIMIT TESTING 152
TABLE 75 MICROBIAL LIMIT TESTING SERVICES MARKET, BY REGION,
2023–2030 (USD MILLION) 152
TABLE 76 VIROLOGY TESTING SERVICES MARKET, BY REGION, 2023–2030 (USD MILLION) 153
TABLE 77 STERILITY TESTING SERVICES MARKET, BY REGION, 2023–2030 (USD MILLION) 154
TABLE 78 ENDOTOXIN TESTING SERVICES MARKET, BY REGION, 2023–2030 (USD MILLION) 155
TABLE 79 PRESERVATIVE EFFICACY TESTING SERVICES MARKET, BY REGION,
2023–2030 (USD MILLION) 156
TABLE 80 OTHER MICROBIAL TESTING SERVICES MARKET, BY REGION,
2023–2030 (USD MILLION) 157
TABLE 81 ENVIRONMENTAL MONITORING SERVICES MARKET, BY TYPE,
2023–2030 (USD MILLION) 158
TABLE 82 ENVIRONMENTAL MONITORING SERVICES MARKET, BY REGION,
2023–2030 (USD MILLION) 158
TABLE 83 PURITY CLASSES FOR PARTICLES, WATER, AND OIL IN COMPRESSED AIR 159
TABLE 84 AIR TESTING SERVICES MARKET, BY REGION, 2023–2030 (USD MILLION) 160
TABLE 85 STANDARDS FOR WASTEWATER QUALITY 160
TABLE 86 WASTEWATER/ETP SERVICES MARKET, BY REGION, 2023–2030 (USD MILLION) 161
TABLE 87 OTHER ENVIRONMENTAL MONITORING SERVICES MARKET, BY REGION,
2023–2030 (USD MILLION) 161
TABLE 88 GENOMIC TESTING SERVICES MARKET, BY REGION, 2023–2030 (USD MILLION) 162
TABLE 89 OTHER ANALYTICAL TESTING SERVICES MARKET, BY REGION,
2023–2030 (USD MILLION) 163
TABLE 90 HEALTHCARE ANALYTICAL TESTING SERVICES MARKET, BY END USER,
2023–2030 (USD MILLION) 165
TABLE 91 HEALTHCARE ANALYTICAL TESTING SERVICES MARKET FOR PHARMACEUTICAL COMPANIES, BY REGION, 2023–2030 (USD MILLION) 166
TABLE 92 HEALTHCARE ANALYTICAL TESTING SERVICES MARKET FOR BIOPHARMACEUTICAL COMPANIES, BY REGION, 2023–2030 (USD MILLION) 167
TABLE 93 HEALTHCARE ANALYTICAL TESTING SERVICES MARKET FOR MEDICAL DEVICE COMPANIES, BY REGION, 2023–2030 (USD MILLION) 169
TABLE 94 HEALTHCARE ANALYTICAL TESTING SERVICES MARKET FOR HOSPITALS & CLINICS, BY REGION, 2023–2030 (USD MILLION) 170
TABLE 95 HEALTHCARE ANALYTICAL TESTING SERVICES MARKET FOR FORENSIC LABS,
BY REGION, 2023–2030 (USD MILLION) 171
TABLE 96 HEALTHCARE ANALYTICAL TESTING SERVICES MARKET FOR COSMETIC & NUTRACEUTICAL COMPANIES, BY REGION, 2023–2030 (USD MILLION) 172
TABLE 97 HEALTHCARE ANALYTICAL TESTING SERVICES MARKET FOR OTHER END USERS, BY REGION, 2023–2030 (USD MILLION) 173
TABLE 98 HEALTHCARE ANALYTICAL TESTING SERVICES MARKET, BY REGION,
2023–2030 (USD MILLION) 175
TABLE 99 NORTH AMERICA: KEY MACROINDICATORS 176
TABLE 100 NORTH AMERICA: HEALTHCARE ANALYTICAL TESTING SERVICES MARKET,
BY COUNTRY, 2023–2030 (USD MILLION) 178
TABLE 101 NORTH AMERICA: HEALTHCARE ANALYTICAL TESTING SERVICES MARKET,
BY TYPE, 2023–2030 (USD MILLION) 178
TABLE 102 NORTH AMERICA: BIOANALYTICAL TESTING SERVICES MARKET, BY TYPE,
2023–2030 (USD MILLION) 179
TABLE 103 NORTH AMERICA: PHYSICAL CHARACTERIZATION SERVICES MARKET, BY TYPE, 2023–2030 (USD MILLION) 179
TABLE 104 NORTH AMERICA: METHOD DEVELOPMENT & VALIDATION SERVICES MARKET,
BY TYPE, 2023–2030 (USD MILLION) 180
TABLE 105 NORTH AMERICA: RAW MATERIAL TESTING SERVICES MARKET, BY TYPE,
2023–2030 (USD MILLION) 180
TABLE 106 NORTH AMERICA: BATCH-RELEASE TESTING SERVICES MARKET, BY TYPE,
2023–2030 (USD MILLION) 181
TABLE 107 NORTH AMERICA: STABILITY TESTING SERVICES MARKET, BY TYPE,
2023–2030 (USD MILLION) 181
TABLE 108 NORTH AMERICA: MICROBIAL TESTING SERVICES MARKET, BY TYPE,
2023–2030 (USD MILLION) 182
TABLE 109 NORTH AMERICA: ENVIRONMENTAL MONITORING SERVICES MARKET,
BY TYPE, 2023–2030 (USD MILLION) 182
TABLE 110 NORTH AMERICA: HEALTHCARE ANALYTICAL TESTING SERVICES MARKET,
BY END USER, 2023–2030 (USD MILLION) 183
TABLE 111 US: HEALTHCARE ANALYTICAL TESTING SERVICES MARKET, BY TYPE,
2023–2030 (USD MILLION) 184
TABLE 112 US: BIOANALYTICAL TESTING SERVICES MARKET, BY TYPE,
2023–2030 (USD MILLION) 184
TABLE 113 US: PHYSICAL CHARACTERIZATION SERVICES MARKET, BY TYPE,
2023–2030 (USD MILLION) 185
TABLE 114 US: METHOD DEVELOPMENT & VALIDATION SERVICES MARKET,
BY TYPE, 2023–2030 (USD MILLION) 185
TABLE 115 US: RAW MATERIAL TESTING SERVICES MARKET, BY TYPE,
2023–2030 (USD MILLION) 186
TABLE 116 US: BATCH-RELEASE TESTING SERVICES MARKET, BY TYPE,
2023–2030 (USD MILLION) 186
TABLE 117 US: STABILITY TESTING SERVICES MARKET, BY TYPE, 2023–2030 (USD MILLION) 187
TABLE 118 US: MICROBIAL TESTING SERVICES MARKET, BY TYPE, 2023–2030 (USD MILLION) 187
TABLE 119 US: ENVIRONMENTAL MONITORING SERVICES MARKET, BY TYPE,
2023–2030 (USD MILLION) 188
TABLE 120 CANADA: HEALTHCARE ANALYTICAL TESTING SERVICES MARKET,
BY TYPE, 2023–2030 (USD MILLION) 189
TABLE 121 CANADA: BIOANALYTICAL TESTING SERVICES MARKET, BY TYPE,
2023–2030 (USD MILLION) 189
TABLE 122 CANADA: PHYSICAL CHARACTERIZATION SERVICES MARKET, BY TYPE,
2023–2030 (USD MILLION) 190
TABLE 123 CANADA: METHOD DEVELOPMENT & VALIDATION SERVICES MARKET, BY TYPE, 2023–2030 (USD MILLION) 190
TABLE 124 CANADA: RAW MATERIAL TESTING SERVICES MARKET, BY TYPE,
2023–2030 (USD MILLION) 191
TABLE 125 CANADA: BATCH-RELEASE TESTING SERVICES MARKET, BY TYPE,
2023–2030 (USD MILLION) 191
TABLE 126 CANADA: STABILITY TESTING SERVICES MARKET, BY TYPE,
2023–2030 (USD MILLION) 192
TABLE 127 CANADA: MICROBIAL TESTING SERVICES MARKET, BY TYPE,
2023–2030 (USD MILLION) 192
TABLE 128 CANADA: ENVIRONMENTAL MONITORING SERVICES MARKET, BY TYPE,
2023–2030 (USD MILLION) 193
TABLE 129 EUROPE: KEY MACROINDICATORS 194
TABLE 130 EUROPE: HEALTHCARE ANALYTICAL TESTING SERVICES MARKET, BY COUNTRY, 2023–2030 (USD MILLION) 194
TABLE 131 EUROPE: HEALTHCARE ANALYTICAL TESTING SERVICES MARKET, BY TYPE,
2023–2030 (USD MILLION) 195
TABLE 132 EUROPE: BIOANALYTICAL TESTING SERVICES MARKET, BY TYPE,
2023–2030 (USD MILLION) 195
TABLE 133 EUROPE: PHYSICAL CHARACTERIZATION SERVICES MARKET, BY TYPE,
2023–2030 (USD MILLION) 196
TABLE 134 EUROPE: METHOD DEVELOPMENT & VALIDATION SERVICES MARKET,
BY TYPE, 2023–2030 (USD MILLION) 196
TABLE 135 EUROPE: RAW MATERIAL TESTING SERVICES MARKET, BY TYPE,
2023–2030 (USD MILLION) 197
TABLE 136 EUROPE: BATCH-RELEASE TESTING SERVICES MARKET, BY TYPE,
2023–2030 (USD MILLION) 197
TABLE 137 EUROPE: STABILITY TESTING SERVICES MARKET, BY TYPE,
2023–2030 (USD MILLION) 198
TABLE 138 EUROPE: MICROBIAL TESTING SERVICES MARKET, BY TYPE,
2023–2030 (USD MILLION) 198
TABLE 139 EUROPE: ENVIRONMENTAL MONITORING SERVICES MARKET,
BY TYPE, 2023–2030 (USD MILLION) 199
TABLE 140 EUROPE: HEALTHCARE ANALYTICAL TESTING SERVICES MARKET,
BY END USER, 2023–2030 (USD MILLION) 199
TABLE 141 GERMANY: HEALTHCARE ANALYTICAL TESTING SERVICES MARKET,
BY TYPE, 2023–2030 (USD MILLION) 201
TABLE 142 GERMANY: BIOANALYTICAL TESTING SERVICES MARKET, BY TYPE,
2023–2030 (USD MILLION) 201
TABLE 143 GERMANY: PHYSICAL CHARACTERIZATION SERVICES MARKET, BY TYPE,
2023–2030 (USD MILLION) 202
TABLE 144 GERMANY: METHOD DEVELOPMENT & VALIDATION SERVICES MARKET,
BY TYPE, 2023–2030 (USD MILLION) 202
TABLE 145 GERMANY: RAW MATERIAL TESTING SERVICES MARKET, BY TYPE,
2023–2030 (USD MILLION) 203
TABLE 146 GERMANY: BATCH-RELEASE TESTING SERVICES MARKET, BY TYPE,
2023–2030 (USD MILLION) 203
TABLE 147 GERMANY: STABILITY TESTING SERVICES MARKET, BY TYPE,
2023–2030 (USD MILLION) 204
TABLE 148 GERMANY: MICROBIAL TESTING SERVICES MARKET, BY TYPE,
2023–2030 (USD MILLION) 204
TABLE 149 GERMANY: ENVIRONMENTAL MONITORING SERVICES MARKET,
BY TYPE, 2023–2030 (USD MILLION) 205
TABLE 150 FRANCE: HEALTHCARE ANALYTICAL TESTING SERVICES MARKET,
BY TYPE, 2023–2030 (USD MILLION) 206
TABLE 151 FRANCE: BIOANALYTICAL TESTING SERVICES MARKET, BY TYPE,
2023–2030 (USD MILLION) 206
TABLE 152 FRANCE: PHYSICAL CHARACTERIZATION SERVICES MARKET, BY TYPE,
2023–2030 (USD MILLION) 207
TABLE 153 FRANCE: METHOD DEVELOPMENT & VALIDATION SERVICES MARKET,
BY TYPE, 2023–2030 (USD MILLION) 207
TABLE 154 FRANCE: RAW MATERIAL TESTING SERVICES MARKET, BY TYPE,
2023–2030 (USD MILLION) 208
TABLE 155 FRANCE: BATCH-RELEASE TESTING SERVICES MARKET, BY TYPE,
2023–2030 (USD MILLION) 208
TABLE 156 FRANCE: STABILITY TESTING SERVICES MARKET, BY TYPE,
2023–2030 (USD MILLION) 209
TABLE 157 FRANCE: MICROBIAL TESTING SERVICES MARKET, BY TYPE,
2023–2030 (USD MILLION) 209
TABLE 158 FRANCE: ENVIRONMENTAL MONITORING SERVICES MARKET, BY TYPE,
2023–2030 (USD MILLION) 210
TABLE 159 UK: HEALTHCARE ANALYTICAL TESTING SERVICES MARKET, BY TYPE,
2023–2030 (USD MILLION) 211
TABLE 160 UK: BIOANALYTICAL TESTING SERVICES MARKET, BY TYPE,
2023–2030 (USD MILLION) 211
TABLE 161 UK: PHYSICAL CHARACTERIZATION SERVICES MARKET, BY TYPE,
2023–2030 (USD MILLION) 212
TABLE 162 UK: METHOD DEVELOPMENT & VALIDATION SERVICES MARKET, BY TYPE,
2023–2030 (USD MILLION) 212
TABLE 163 UK: RAW MATERIAL TESTING SERVICES MARKET, BY TYPE,
2023–2030 (USD MILLION) 213
TABLE 164 UK: BATCH-RELEASE TESTING SERVICES MARKET, BY TYPE,
2023–2030 (USD MILLION) 213
TABLE 165 UK: STABILITY TESTING SERVICES MARKET, BY TYPE, 2023–2030 (USD MILLION) 214
TABLE 166 UK: MICROBIAL TESTING SERVICES MARKET, BY TYPE, 2023–2030 (USD MILLION) 214
TABLE 167 UK: ENVIRONMENTAL MONITORING SERVICES MARKET, BY TYPE,
2023–2030 (USD MILLION) 215
TABLE 168 ITALY: HEALTHCARE ANALYTICAL TESTING SERVICES MARKET, BY TYPE,
2023–2030 (USD MILLION) 216
TABLE 169 ITALY: BIOANALYTICAL TESTING SERVICES MARKET, BY TYPE,
2023–2030 (USD MILLION) 216
TABLE 170 ITALY: PHYSICAL CHARACTERIZATION SERVICES MARKET, BY TYPE,
2023–2030 (USD MILLION) 217
TABLE 171 ITALY: METHOD DEVELOPMENT & VALIDATION SERVICES MARKET,
BY TYPE, 2023–2030 (USD MILLION) 217
TABLE 172 ITALY: RAW MATERIAL TESTING SERVICES MARKET, BY TYPE,
2023–2030 (USD MILLION) 218
TABLE 173 ITALY: BATCH-RELEASE TESTING SERVICES MARKET, BY TYPE,
2023–2030 (USD MILLION) 218
TABLE 174 ITALY: STABILITY TESTING SERVICES MARKET, BY TYPE,
2023–2030 (USD MILLION) 219
TABLE 175 ITALY: MICROBIAL TESTING SERVICES MARKET, BY TYPE,
2023–2030 (USD MILLION) 219
TABLE 176 ITALY: ENVIRONMENTAL MONITORING SERVICES MARKET, BY TYPE,
2023–2030 (USD MILLION) 220
TABLE 177 SWITZERLAND: HEALTHCARE ANALYTICAL TESTING SERVICES MARKET,
BY TYPE, 2023–2030 (USD MILLION) 221
TABLE 178 SWITZERLAND: BIOANALYTICAL TESTING SERVICES MARKET, BY TYPE,
2023–2030 (USD MILLION) 221
TABLE 179 SWITZERLAND: PHYSICAL CHARACTERIZATION SERVICES MARKET, BY TYPE, 2023–2030 (USD MILLION) 222
TABLE 180 SWITZERLAND: METHOD DEVELOPMENT & VALIDATION SERVICES MARKET,
BY TYPE, 2023–2030 (USD MILLION) 222
TABLE 181 SWITZERLAND: RAW MATERIAL TESTING SERVICES MARKET, BY TYPE,
2023–2030 (USD MILLION) 223
TABLE 182 SWITZERLAND: BATCH-RELEASE TESTING SERVICES MARKET, BY TYPE,
2023–2030 (USD MILLION) 223
TABLE 183 SWITZERLAND: STABILITY TESTING SERVICES MARKET, BY TYPE,
2023–2030 (USD MILLION) 224
TABLE 184 SWITZERLAND: MICROBIAL TESTING SERVICES MARKET, BY TYPE,
2023–2030 (USD MILLION) 224
TABLE 185 SWITZERLAND: ENVIRONMENTAL MONITORING SERVICES MARKET,
BY TYPE, 2023–2030 (USD MILLION) 225
TABLE 186 SPAIN: HEALTHCARE ANALYTICAL TESTING SERVICES MARKET, BY TYPE,
2023–2030 (USD MILLION) 226
TABLE 187 SPAIN: BIOANALYTICAL TESTING SERVICES MARKET, BY TYPE,
2023–2030 (USD MILLION) 226
TABLE 188 SPAIN: PHYSICAL CHARACTERIZATION SERVICES MARKET, BY TYPE,
2023–2030 (USD MILLION) 227
TABLE 189 SPAIN: METHOD DEVELOPMENT & VALIDATION SERVICES MARKET,
BY TYPE, 2023–2030 (USD MILLION) 227
TABLE 190 SPAIN: RAW MATERIAL TESTING SERVICES MARKET, BY TYPE,
2023–2030 (USD MILLION) 228
TABLE 191 SPAIN: BATCH-RELEASE TESTING SERVICES MARKET, BY TYPE,
2023–2030 (USD MILLION) 228
TABLE 192 SPAIN: STABILITY TESTING SERVICES MARKET, BY TYPE,
2023–2030 (USD MILLION) 229
TABLE 193 SPAIN: MICROBIAL TESTING SERVICES MARKET, BY TYPE,
2023–2030 (USD MILLION) 229
TABLE 194 SPAIN: ENVIRONMENTAL MONITORING SERVICES MARKET,
BY TYPE, 2023–2030 (USD MILLION) 230
TABLE 195 REST OF EUROPE: HEALTHCARE ANALYTICAL TESTING SERVICES MARKET,
BY TYPE, 2023–2030 (USD MILLION) 231
TABLE 196 REST OF EUROPE: BIOANALYTICAL TESTING SERVICES MARKET,
BY TYPE, 2023–2030 (USD MILLION) 232
TABLE 197 REST OF EUROPE: PHYSICAL CHARACTERIZATION SERVICES MARKET, BY TYPE, 2023–2030 (USD MILLION) 232
TABLE 198 REST OF EUROPE: METHOD DEVELOPMENT & VALIDATION SERVICES MARKET,
BY TYPE, 2023–2030 (USD MILLION) 233
TABLE 199 REST OF EUROPE: RAW MATERIAL TESTING SERVICES MARKET, BY TYPE,
2023–2030 (USD MILLION) 233
TABLE 200 REST OF EUROPE: BATCH-RELEASE TESTING SERVICES MARKET, BY TYPE,
2023–2030 (USD MILLION) 234
TABLE 201 REST OF EUROPE: STABILITY TESTING SERVICES MARKET, BY TYPE,
2023–2030 (USD MILLION) 234
TABLE 202 REST OF EUROPE: MICROBIAL TESTING SERVICES MARKET, BY TYPE,
2023–2030 (USD MILLION) 235
TABLE 203 REST OF EUR0PE: ENVIRONMENTAL MONITORING SERVICES MARKET,
BY TYPE, 2023–2030 (USD MILLION) 235
TABLE 204 ASIA PACIFIC: MACROECONOMIC INDICATORS 236
TABLE 205 ASIA PACIFIC: HEALTHCARE ANALYTICAL TESTING SERVICES MARKET,
BY COUNTRY, 2023–2030 (USD MILLION) 238
TABLE 206 ASIA PACIFIC: HEALTHCARE ANALYTICAL TESTING SERVICES MARKET,
BY TYPE, 2023–2030 (USD MILLION) 238
TABLE 207 ASIA PACIFIC: BIOANALYTICAL TESTING SERVICES MARKET, BY TYPE,
2023–2030 (USD MILLION) 239
TABLE 208 ASIA PACIFIC: PHYSICAL CHARACTERIZATION SERVICES MARKET, BY TYPE,
2023–2030 (USD MILLION) 239
TABLE 209 ASIA PACIFIC: METHOD DEVELOPMENT & VALIDATION SERVICES MARKET,
BY TYPE, 2023–2030 (USD MILLION) 240
TABLE 210 ASIA PACIFIC: RAW MATERIAL TESTING SERVICES MARKET, BY TYPE,
2023–2030 (USD MILLION) 240
TABLE 211 ASIA PACIFIC: BATCH-RELEASE TESTING SERVICES MARKET, BY TYPE,
2023–2030 (USD MILLION) 241
TABLE 212 ASIA PACIFIC: STABILITY TESTING SERVICES MARKET, BY TYPE,
2023–2030 (USD MILLION) 241
TABLE 213 ASIA PACIFIC: MICROBIAL TESTING SERVICES MARKET, BY TYPE,
2023–2030 (USD MILLION) 242
TABLE 214 ASIA PACIFIC: ENVIRONMENTAL MONITORING SERVICES MARKET,
BY TYPE, 2023–2030 (USD MILLION) 242
TABLE 215 ASIA PACIFIC: HEALTHCARE ANALYTICAL TESTING SERVICES MARKET,
BY END USER, 2023–2030 (USD MILLION) 243
TABLE 216 JAPAN: HEALTHCARE ANALYTICAL TESTING SERVICES MARKET,
BY TYPE, 2023–2030 (USD MILLION) 244
TABLE 217 JAPAN: BIOANALYTICAL TESTING SERVICES MARKET, BY TYPE,
2023–2030 (USD MILLION) 244
TABLE 218 JAPAN: PHYSICAL CHARACTERIZATION SERVICES MARKET, BY TYPE,
2023–2030 (USD MILLION) 245
TABLE 219 JAPAN: METHOD DEVELOPMENT & VALIDATION SERVICES MARKET,
BY TYPE, 2023–2030 (USD MILLION) 245
TABLE 220 JAPAN: RAW MATERIAL TESTING SERVICES MARKET, BY TYPE,
2023–2030 (USD MILLION) 246
TABLE 221 JAPAN: BATCH-RELEASE TESTING SERVICES MARKET, BY TYPE,
2023–2030 (USD MILLION) 246
TABLE 222 JAPAN: STABILITY TESTING SERVICES MARKET, BY TYPE,
2023–2030 (USD MILLION) 247
TABLE 223 JAPAN: MICROBIAL TESTING SERVICES MARKET, BY TYPE,
2023–2030 (USD MILLION) 247
TABLE 224 JAPAN: ENVIRONMENTAL MONITORING SERVICES MARKET, BY TYPE,
2023–2030 (USD MILLION) 248
TABLE 225 CHINA: HEALTHCARE ANALYTICAL TESTING SERVICES MARKET, BY TYPE,
2023–2030 (USD MILLION) 249
TABLE 226 CHINA: BIOANALYTICAL TESTING SERVICES MARKET, BY TYPE,
2023–2030 (USD MILLION) 249
TABLE 227 CHINA: PHYSICAL CHARACTERIZATION SERVICES MARKET, BY TYPE,
2023–2030 (USD MILLION) 250
TABLE 228 CHINA: METHOD DEVELOPMENT & VALIDATION SERVICES MARKET,
BY TYPE, 2023–2030 (USD MILLION) 250
TABLE 229 CHINA: RAW MATERIAL TESTING SERVICES MARKET, BY TYPE,
2023–2030 (USD MILLION) 251
TABLE 230 CHINA: BATCH-RELEASE TESTING SERVICES MARKET, BY TYPE,
2023–2030 (USD MILLION) 251
TABLE 231 CHINA: STABILITY TESTING SERVICES MARKET, BY TYPE,
2023–2030 (USD MILLION) 252
TABLE 232 CHINA: MICROBIAL TESTING SERVICES MARKET, BY TYPE,
2023–2030 (USD MILLION) 252
TABLE 233 CHINA: ENVIRONMENTAL MONITORING SERVICES MARKET,
BY TYPE, 2023–2030 (USD MILLION) 253
TABLE 234 INDIA: HEALTHCARE ANALYTICAL TESTING SERVICES MARKET, BY TYPE,
2023–2030 (USD MILLION) 254
TABLE 235 INDIA: BIOANALYTICAL TESTING SERVICES MARKET, BY TYPE,
2023–2030 (USD MILLION) 254
TABLE 236 INDIA: PHYSICAL CHARACTERIZATION SERVICES MARKET, BY TYPE,
2023–2030 (USD MILLION) 255
TABLE 237 INDIA: METHOD DEVELOPMENT & VALIDATION SERVICES MARKET, BY TYPE, 2023–2030 (USD MILLION) 255
TABLE 238 INDIA: RAW MATERIAL TESTING SERVICES MARKET, BY TYPE,
2023–2030 (USD MILLION) 256
TABLE 239 INDIA: BATCH-RELEASE TESTING SERVICES MARKET, BY TYPE,
2023–2030 (USD MILLION) 256
TABLE 240 INDIA: STABILITY TESTING SERVICES MARKET, BY TYPE,
2023–2030 (USD MILLION) 257
TABLE 241 INDIA: MICROBIAL TESTING SERVICES MARKET, BY TYPE,
2023–2030 (USD MILLION) 257
TABLE 242 INDIA: ENVIRONMENTAL MONITORING SERVICES MARKET, BY TYPE,
2023–2030 (USD MILLION) 258
TABLE 243 AUSTRALIA: HEALTHCARE ANALYTICAL TESTING SERVICES MARKET,
BY TYPE, 2023–2030 (USD MILLION) 259
TABLE 244 AUSTRALIA: BIOANALYTICAL TESTING SERVICES MARKET, BY TYPE,
2023–2030 (USD MILLION) 259
TABLE 245 AUSTRALIA: PHYSICAL CHARACTERIZATION SERVICES MARKET, BY TYPE,
2023–2030 (USD MILLION) 260
TABLE 246 AUSTRALIA: METHOD DEVELOPMENT & VALIDATION SERVICES MARKET,
BY TYPE, 2023–2030 (USD MILLION) 260
TABLE 247 AUSTRALIA: RAW MATERIAL TESTING SERVICES MARKET, BY TYPE,
2023–2030 (USD MILLION) 261
TABLE 248 AUSTRALIA: BATCH-RELEASE TESTING SERVICES MARKET, BY TYPE,
2023–2030 (USD MILLION) 261
TABLE 249 AUSTRALIA: STABILITY TESTING SERVICES MARKET, BY TYPE,
2023–2030 (USD MILLION) 262
TABLE 250 AUSTRALIA: MICROBIAL TESTING SERVICES MARKET, BY TYPE,
2023–2030 (USD MILLION) 262
TABLE 251 AUSTRALIA: ENVIRONMENTAL MONITORING SERVICES MARKET,
BY TYPE, 2023–2030 (USD MILLION) 263
TABLE 252 SOUTH KOREA: HEALTHCARE ANALYTICAL TESTING SERVICES MARKET,
BY TYPE, 2023–2030 (USD MILLION) 264
TABLE 253 SOUTH KOREA: BIOANALYTICAL TESTING SERVICES MARKET, BY TYPE,
2023–2030 (USD MILLION) 264
TABLE 254 SOUTH KOREA: PHYSICAL CHARACTERIZATION SERVICES MARKET,
BY TYPE, 2023–2030 (USD MILLION) 265
TABLE 255 SOUTH KOREA: METHOD DEVELOPMENT & VALIDATION SERVICES MARKET,
BY TYPE, 2023–2030 (USD MILLION) 265
TABLE 256 SOUTH KOREA: RAW MATERIAL TESTING SERVICES MARKET, BY TYPE,
2023–2030 (USD MILLION) 266
TABLE 257 SOUTH KOREA: BATCH-RELEASE TESTING SERVICES MARKET, BY TYPE,
2023–2030 (USD MILLION) 266
TABLE 258 SOUTH KOREA: STABILITY TESTING SERVICES MARKET, BY TYPE,
2023–2030 (USD MILLION) 267
TABLE 259 SOUTH KOREA: MICROBIAL TESTING SERVICES MARKET, BY TYPE,
2023–2030 (USD MILLION) 267
TABLE 260 SOUTH KOREA: ENVIRONMENTAL MONITORING SERVICES MARKET,
BY TYPE, 2023–2030 (USD MILLION) 268
TABLE 261 REST OF ASIA PACIFIC: HEALTHCARE ANALYTICAL TESTING SERVICES MARKET,
BY TYPE, 2023–2030 (USD MILLION) 269
TABLE 262 REST OF ASIA PACIFIC: BIOANALYTICAL TESTING SERVICES MARKET,
BY TYPE, 2023–2030 (USD MILLION) 269
TABLE 263 REST OF ASIA PACIFIC: PHYSICAL CHARACTERIZATION SERVICES MARKET,
BY TYPE, 2023–2030 (USD MILLION) 270
TABLE 264 REST OF ASIA PACIFIC: METHOD DEVELOPMENT & VALIDATION SERVICES MARKET, BY TYPE, 2023–2030 (USD MILLION) 270
TABLE 265 REST OF ASIA PACIFIC: RAW MATERIAL TESTING SERVICES MARKET,
BY TYPE, 2023–2030 (USD MILLION) 271
TABLE 266 REST OF ASIA PACIFIC: BATCH-RELEASE TESTING SERVICES MARKET,
BY TYPE, 2023–2030 (USD MILLION) 271
TABLE 267 REST OF ASIA PACIFIC: STABILITY TESTING SERVICES MARKET,
BY TYPE, 2023–2030 (USD MILLION) 272
TABLE 268 REST OF ASIA PACIFIC: MICROBIAL TESTING SERVICES MARKET,
BY TYPE, 2023–2030 (USD MILLION) 272
TABLE 269 REST OF ASIA PACIFIC: ENVIRONMENTAL MONITORING SERVICES MARKET,
BY TYPE, 2023–2030 (USD MILLION) 273
TABLE 270 LATIN AMERICA: KEY MACROINDICATORS 274
TABLE 271 LATIN AMERICA: HEALTHCARE ANALYTICAL TESTING SERVICES MARKET,
BY COUNTRY, 2023–2030 (USD MILLION) 274
TABLE 272 LATIN AMERICA: HEALTHCARE ANALYTICAL TESTING SERVICES MARKET,
BY TYPE, 2023–2030 (USD MILLION) 275
TABLE 273 LATIN AMERICA: BIOANALYTICAL TESTING SERVICES MARKET, BY TYPE,
2023–2030 (USD MILLION) 275
TABLE 274 LATIN AMERICA: PHYSICAL CHARACTERIZATION SERVICES MARKET,
BY TYPE, 2023–2030 (USD MILLION) 276
TABLE 275 LATIN AMERICA: METHOD DEVELOPMENT & VALIDATION SERVICES MARKET,
BY TYPE, 2023–2030 (USD MILLION) 276
TABLE 276 LATIN AMERICA: RAW MATERIAL TESTING SERVICES MARKET, BY TYPE,
2023–2030 (USD MILLION) 277
TABLE 277 LATIN AMERICA: BATCH-RELEASE TESTING SERVICES MARKET, BY TYPE,
2023–2030 (USD MILLION) 277
TABLE 278 LATIN AMERICA: STABILITY TESTING SERVICES MARKET, BY TYPE,
2023–2030 (USD MILLION) 278
TABLE 279 LATIN AMERICA: MICROBIAL TESTING SERVICES MARKET, BY TYPE,
2023–2030 (USD MILLION) 278
TABLE 280 LATIN AMERICA: ENVIRONMENTAL MONITORING SERVICES MARKET,
BY TYPE, 2023–2030 (USD MILLION) 279
TABLE 281 LATIN AMERICA: HEALTHCARE ANALYTICAL TESTING SERVICES MARKET,
BY END USER, 2023–2030 (USD MILLION) 279
TABLE 282 BRAZIL: HEALTHCARE ANALYTICAL TESTING SERVICES MARKET, BY TYPE,
2023–2030 (USD MILLION) 280
TABLE 283 BRAZIL: BIOANALYTICAL TESTING SERVICES MARKET, BY TYPE,
2023–2030 (USD MILLION) 281
TABLE 284 BRAZIL: PHYSICAL CHARACTERIZATION SERVICES MARKET, BY TYPE,
2023–2030 (USD MILLION) 281
TABLE 285 BRAZIL: METHOD DEVELOPMENT & VALIDATION SERVICES MARKET,
BY TYPE, 2023–2030 (USD MILLION) 282
TABLE 286 BRAZIL: RAW MATERIAL TESTING SERVICES MARKET, BY TYPE,
2023–2030 (USD MILLION) 282
TABLE 287 BRAZIL: BATCH-RELEASE TESTING SERVICES MARKET, BY TYPE,
2023–2030 (USD MILLION) 283
TABLE 288 BRAZIL: STABILITY TESTING SERVICES MARKET, BY TYPE,
2023–2030 (USD MILLION) 283
TABLE 289 BRAZIL: MICROBIAL TESTING SERVICES MARKET, BY TYPE,
2023–2030 (USD MILLION) 284
TABLE 290 BRAZIL: ENVIRONMENTAL MONITORING SERVICES MARKET, BY TYPE,
2023–2030 (USD MILLION) 284
TABLE 291 MEXICO: HEALTHCARE ANALYTICAL TESTING SERVICES MARKET, BY TYPE,
2023–2030 (USD MILLION) 285
TABLE 292 MEXICO: BIOANALYTICAL TESTING SERVICES MARKET, BY TYPE,
2023–2030 (USD MILLION) 286
TABLE 293 MEXICO: PHYSICAL CHARACTERIZATION SERVICES MARKET, BY TYPE,
2023–2030 (USD MILLION) 286
TABLE 294 MEXICO: METHOD DEVELOPMENT & VALIDATION SERVICES MARKET,
BY TYPE, 2023–2030 (USD MILLION) 287
TABLE 295 MEXICO: RAW MATERIAL TESTING SERVICES MARKET, BY TYPE,
2023–2030 (USD MILLION) 287
TABLE 296 MEXICO: BATCH-RELEASE TESTING SERVICES MARKET, BY TYPE,
2023–2030 (USD MILLION) 288
TABLE 297 MEXICO: STABILITY TESTING SERVICES MARKET, BY TYPE,
2023–2030 (USD MILLION) 288
TABLE 298 MEXICO: MICROBIAL TESTING SERVICES MARKET, BY TYPE,
2023–2030 (USD MILLION) 289
TABLE 299 MEXICO: ENVIRONMENTAL MONITORING SERVICES MARKET, BY TYPE,
2023–2030 (USD MILLION) 289
TABLE 300 REST OF LATIN AMERICA: HEALTHCARE ANALYTICAL TESTING SERVICES MARKET, BY TYPE, 2023–2030 (USD MILLION) 290
TABLE 301 REST OF LATIN AMERICA: BIOANALYTICAL TESTING SERVICES MARKET,
BY TYPE, 2023–2030 (USD MILLION) 290
TABLE 302 REST OF LATIN AMERICA: PHYSICAL CHARACTERIZATION SERVICES MARKET,
BY TYPE, 2023–2030 (USD MILLION) 291
TABLE 303 REST OF LATIN AMERICA: METHOD DEVELOPMENT & VALIDATION SERVICES MARKET, BY TYPE, 2023–2030 (USD MILLION) 291
TABLE 304 REST OF LATIN AMERICA: RAW MATERIAL TESTING SERVICES MARKET,
BY TYPE, 2023–2030 (USD MILLION) 292
TABLE 305 REST OF LATIN AMERICA: BATCH-RELEASE TESTING SERVICES MARKET,
BY TYPE, 2023–2030 (USD MILLION) 292
TABLE 306 REST OF LATIN AMERICA: STABILITY TESTING SERVICES MARKET, BY TYPE,
2023–2030 (USD MILLION) 293
TABLE 307 REST OF LATIN AMERICA: MICROBIAL TESTING SERVICES MARKET,
BY TYPE, 2023–2030 (USD MILLION) 293
TABLE 308 REST OF LATIN AMERICA: ENVIRONMENTAL MONITORING SERVICES MARKET,
BY TYPE, 2023–2030 (USD MILLION) 294
TABLE 309 MIDDLE EAST & AFRICA: KEY MACROINDICATORS 295
TABLE 310 MIDDLE EAST & AFRICA: HEALTHCARE ANALYTICAL TESTING SERVICES MARKET, BY REGION, 2023–2030 (USD MILLION) 295
TABLE 311 MIDDLE EAST & AFRICA: HEALTHCARE ANALYTICAL TESTING SERVICES MARKET, BY TYPE, 2023–2030 (USD MILLION) 296
TABLE 312 MIDDLE EAST & AFRICA: BIOANALYTICAL TESTING SERVICES MARKET,
BY TYPE, 2023–2030 (USD MILLION) 296
TABLE 313 MIDDLE EAST & AFRICA: PHYSICAL CHARACTERIZATION SERVICES MARKET,
BY TYPE, 2023–2030 (USD MILLION) 297
TABLE 314 MIDDLE EAST & AFRICA: METHOD DEVELOPMENT & VALIDATION SERVICES MARKET, BY TYPE, 2023–2030 (USD MILLION) 297
TABLE 315 MIDDLE EAST & AFRICA: RAW MATERIAL TESTING SERVICES MARKET,
BY TYPE, 2023–2030 (USD MILLION) 298
TABLE 316 MIDDLE EAST & AFRICA: BATCH-RELEASE TESTING SERVICES MARKET,
BY TYPE, 2023–2030 (USD MILLION) 298
TABLE 317 MIDDLE EAST & AFRICA: STABILITY TESTING SERVICES MARKET,
BY TYPE, 2023–2030 (USD MILLION) 299
TABLE 318 MIDDLE EAST & AFRICA: MICROBIAL TESTING SERVICES MARKET,
BY TYPE, 2023–2030 (USD MILLION) 299
TABLE 319 MIDDLE EAST & AFRICA: ENVIRONMENTAL MONITORING SERVICES MARKET,
BY TYPE, 2023–2030 (USD MILLION) 300
TABLE 320 MIDDLE EAST & AFRICA: HEALTHCARE ANALYTICAL TESTING SERVICES MARKET, BY END USER, 2023–2030 (USD MILLION) 300
TABLE 321 GCC COUNTRIES: HEALTHCARE ANALYTICAL TESTING SERVICES MARKET,
BY TYPE, 2023–2030 (USD MILLION) 301
TABLE 322 GCC COUNTRIES: BIOANALYTICAL TESTING SERVICES MARKET, BY TYPE,
2023–2030 (USD MILLION) 301
TABLE 323 GCC COUNTRIES: PHYSICAL CHARACTERIZATION SERVICES MARKET,
BY TYPE, 2023–2030 (USD MILLION) 302
TABLE 324 GCC COUNTRIES: METHOD DEVELOPMENT & VALIDATION SERVICES MARKET,
BY TYPE, 2023–2030 (USD MILLION) 302
TABLE 325 GCC COUNTRIES: RAW MATERIAL TESTING SERVICES MARKET, BY TYPE,
2023–2030 (USD MILLION) 303
TABLE 326 GCC COUNTRIES: BATCH-RELEASE TESTING SERVICES MARKET, BY TYPE,
2023–2030 (USD MILLION) 303
TABLE 327 GCC COUNTRIES: STABILITY TESTING SERVICES MARKET, BY TYPE,
2023–2030 (USD MILLION) 304
TABLE 328 GCC COUNTRIES: MICROBIAL TESTING SERVICES MARKET, BY TYPE,
2023–2030 (USD MILLION) 304
TABLE 329 GCC COUNTRIES: ENVIRONMENTAL MONITORING SERVICES MARKET,
BY TYPE, 2023–2030 (USD MILLION) 305
TABLE 330 REST OF MIDDLE EAST & AFRICA: HEALTHCARE ANALYTICAL TESTING SERVICES MARKET, BY TYPE, 2023–2030 (USD MILLION) 305
TABLE 331 REST OF MIDDLE EAST & AFRICA: BIOANALYTICAL TESTING SERVICES MARKET,
BY TYPE, 2023–2030 (USD MILLION) 306
TABLE 332 REST OF MIDDLE EAST & AFRICA: BUBIOANAZATION SERVICES MARKET, BY TYPE, 2023–2030 (USD MILLION) 306
TABLE 333 REST OF MIDDLE EAST & AFRICA: METHOD DEVELOPMENT & VALIDATION SERVICES MARKET, BY TYPE, 2023–2030 (USD MILLION) 307
TABLE 334 REST OF MIDDLE EAST & AFRICA: RAW MATERIAL TESTING SERVICES MARKET,
BY TYPE, 2023–2030 (USD MILLION) 307
TABLE 335 REST OF MIDDLE EAST & AFRICA: BATCH-RELEASE TESTING SERVICES MARKET, BY TYPE, 2023–2030 (USD MILLION) 308
TABLE 336 REST OF MIDDLE EAST & AFRICA: STABILITY TESTING SERVICES MARKET,
BY TYPE, 2023–2030 (USD MILLION) 308
TABLE 337 REST OF MIDDLE EAST & AFRICA: MICROBIAL TESTING SERVICES MARKET,
BY TYPE, 2023–2030 (USD MILLION) 309
TABLE 338 REST OF MIDDLE EAST & AFRICA: ENVIRONMENTAL MONITORING SERVICES MARKET, BY TYPE, 2023–2030 (USD MILLION) 309
TABLE 339 OVERVIEW OF STRATEGIES DEPLOYED BY KEY PLAYERS IN HEALTHCARE ANALYTICAL TESTING SERVICES MARKET 310
TABLE 340 HEALTHCARE ANALYTICAL TESTING SERVICES MARKET: DEGREE OF COMPETITION 314
TABLE 341 HEALTHCARE ANALYTICAL TESTING SERVICES MARKET: REGION FOOTPRINT 319
TABLE 342 HEALTHCARE ANALYTICAL TESTING SERVICES MARKET: TYPE FOOTPRINT 320
TABLE 343 HEALTHCARE ANALYTICAL TESTING SERVICES MARKET: END-USER FOOTPRINT 321
TABLE 344 HEALTHCARE ANALYTICAL TESTING SERVICES MARKET: DETAILED LIST OF STARTUPS/SMES 324
TABLE 345 HEALTHCARE ANALYTICAL TESTING SERVICES MARKET: COMPETITIVE BENCHMARKING OF EMERGING PLAYERS/STARTUPS 325
TABLE 346 HEALTHCARE ANALYTICAL TESTING SERVICES MARKET: SERVICE LAUNCHES, JANUARY 2021–MAY 2025 329
TABLE 347 HEALTHCARE ANALYTICAL TESTING SERVICES MARKET:
DEALS, JANUARY 2021– JUNE 2025 330
TABLE 348 HEALTHCARE ANALYTICAL TESTING SERVICES MARKET:
EXPANSIONS, JANUARY 2021– JUNE 2025 331
TABLE 349 EUROFINS SCIENTIFIC SE: COMPANY OVERVIEW 333
TABLE 350 EUROFINS SCIENTIFIC SE: SERVICES OFFERED 334
TABLE 351 EUROFINS SCIENTIFIC SE: DEALS, JANUARY 2021–JUNE 2025 336
TABLE 352 EUROFINS SCIENTIFIC SE: EXPANSIONS, JANUARY 2021–JUNE 2025 337
TABLE 353 LABCORP HOLDINGS INC.: COMPANY OVERVIEW 339
TABLE 354 LABCORP HOLDINGS INC.: SERVICES OFFERED 340
TABLE 355 LABCORP HOLDINGS INC.: SERVICE LAUNCHES, JANUARY 2021–JUNE 2025 341
TABLE 356 LABCORP HOLDINGS INC.: DEALS, JANUARY 2021–JUNE 2025 341
TABLE 357 LABCORP HOLDINGS INC.: EXPANSIONS, JANUARY 2021–JUNE 2025 342
TABLE 358 INTERTEK GROUP PLC: COMPANY OVERVIEW 344
TABLE 359 INTERTEK GROUP PLC: SERVICES OFFERED 345
TABLE 360 INTERTEK GROUP PLC: DEALS, JANUARY 2021–JUNE 2025 349
TABLE 361 INTERTEK GROUP PLC: EXPANSIONS, JANUARY 2021–JUNE 2025 349
TABLE 362 ICON PLC: COMPANY OVERVIEW 351
TABLE 363 ICON PLC: SERVICES OFFERED 352
TABLE 364 ICON PLC: DEALS, JANUARY 2021–JUNE 2025 353
TABLE 365 IQVIA INC.: COMPANY OVERVIEW 355
TABLE 366 IQVIA HOLDINGS INC.: SERVICES OFFERED 356
TABLE 367 IQVIA INC.: EXPANSIONS, JANUARY 2021–JUNE 2025 357
TABLE 368 IQVIA INC.: OTHER DEVELOPMENTS, JANUARY 2021–JUNE 2025 358
TABLE 369 WUXI APPTEC CO., LTD.: COMPANY OVERVIEW 359
TABLE 370 WUXI APPTEC CO., LTD.: SERVICES OFFERED 360
TABLE 371 WUXI APPTEC CO., LTD.: SERVICE LAUNCHES, JANUARY 2021–JUNE 2025 361
TABLE 372 WUXI APPTEC CO., LTD.: DEALS, JANUARY 2021–JUNE 2025 362
TABLE 373 WUXI APPTEC CO., LTD.: EXPANSIONS, JANUARY 2021–JUNE 2025 362
TABLE 374 CHARLES RIVER LABORATORIES: COMPANY OVERVIEW 363
TABLE 375 CHARLES RIVER LABORATORIES INTERNATIONAL, INC.: SERVICES OFFERED 364
TABLE 376 CHARLES RIVER LABORATORIES: SERVICE LAUNCHES & APPROVALS,
JANUARY 2021–JUNE 2025 365
TABLE 377 CHARLES RIVER LABORATORIES: DEALS, JANUARY 2021–JUNE 2025 366
TABLE 378 CHARLES RIVER LABORATORIES: EXPANSIONS, JANUARY 2021–JUNE 2025 367
TABLE 379 SGS SA: COMPANY OVERVIEW 368
TABLE 380 SGS SA: SERVICES OFFERED 369
TABLE 381 SGS SA: SERVICE LAUNCHES, JANUARY 2021–JUNE 2025 371
TABLE 382 SGS SA: DEALS, JANUARY 2021–JUNE 2025 371
TABLE 383 SGS SA: EXPANSIONS, JANUARY 2021–JUNE 2025 372
TABLE 384 SGS SA: OTHER DEVELOPMENTS, JANUARY 2021–JUNE 2025 373
TABLE 385 THERMO FISHER SCIENTIFIC INC.: COMPANY OVERVIEW 374
TABLE 386 THERMO FISHER SCIENTIFIC INC.: SERVICES OFFERED 375
TABLE 387 THERMO FISHER SCIENTIFIC INC.: DEALS, JANUARY 2021–JUNE 2025 376
TABLE 388 THERMO FISHER SCIENTIFIC INC.: EXPANSIONS, JANUARY 2021–JUNE 2025 377
TABLE 389 MEDPACE HOLDINGS, INC.: COMPANY OVERVIEW 378
TABLE 390 MEDPACE HOLDINGS, INC.: SERVICES OFFERED 379
TABLE 391 MEDPACE HOLDINGS, INC.: DEALS, JANUARY 2021–JUNE 2025 380
TABLE 392 MEDPACE HOLDINGS, INC.: EXPANSIONS, JANUARY 2021–JUNE 2025 380
TABLE 393 SARTORIUS AG: COMPANY OVERVIEW 381
TABLE 394 SARTORIUS AG: SERVICES OFFERED 382
TABLE 395 SARTORIUS AG: DEALS, JANUARY 2021–JUNE 2025 383
TABLE 396 SARTORIUS AG: EXPANSIONS, JANUARY 2021–JUNE 2025 383
TABLE 397 MERCK KGAA: COMPANY OVERVIEW 384
TABLE 398 MERCK KGAA: SERVICES OFFERED 385
TABLE 399 MERCK KGAA: SERVICE LAUNCHES, JANUARY 2021–JUNE 2025 386
TABLE 400 MERCK KGAA: DEALS, JANUARY 2021–JUNE 2025 386
TABLE 401 MERCK KGAA: EXPANSIONS, JANUARY 2021–JUNE 2025 387
TABLE 402 MERCK KGAA: OTHER DEVELOPMENTS, JANUARY 2021–JUNE 2025 387
TABLE 403 SOURCEBIO INTERNATIONAL PLC: COMPANY OVERVIEW 389
TABLE 404 SOURCEBIO INTERNATIONAL PLC: SERVICES OFFERED 390
TABLE 405 SOURCEBIO INTERNATIONAL PLC: SERVICE LAUNCHES,
JANUARY 2021–JUNE 2025 390
TABLE 406 SOURCEBIO INTERNATIONAL PLC: EXPANSIONS, JANUARY 2021–JUNE 2025 391
TABLE 407 ALS: COMPANY OVERVIEW 392
TABLE 408 ALS: SERVICES OFFERED 393
TABLE 409 ALS: DEALS, JANUARY 2021–JUNE 2025 394
TABLE 410 FRONTAGE LABORATORIES, INC.: COMPANY OVERVIEW 395
TABLE 411 FRONTAGE LABORATORIES, INC.: SERVICES OFFERED 396
TABLE 412 FRONTAGE LABORATORIES, INC.: DEALS, JANUARY 2021–JUNE 2025 398
TABLE 413 FRONTAGE LABORATORIES, INC.: EXPANSIONS, JANUARY 2021–JUNE 2025 398
TABLE 414 STERIS: COMPANY OVERVIEW 399
TABLE 415 STERIS PLC: SERVICES OFFERED 400
TABLE 416 STERIS PLC: SERVICE LAUNCHES, JANUARY 2021–JUNE 2025 401
TABLE 417 STERIS PLC: EXPANSIONS, JANUARY 2021–JUNE 2025 401
TABLE 418 STERIS PLC: OTHER DEVELOPMENTS, JANUARY 2021–JUNE 2025 402
TABLE 419 ELEMENT MATERIALS TECHNOLOGY: COMPANY OVERVIEW 403
TABLE 420 ELEMENT MATERIALS TECHNOLOGY: SERVICES OFFERED 403
TABLE 421 ELEMENT MATERIALS TECHNOLOGY: SERVICE LAUNCHES,
JANUARY 2021–JUNE 2025 404
TABLE 422 ELEMENT MATERIALS TECHNOLOGY: DEALS, JANUARY 2021–JUNE 2025 404
TABLE 423 ELEMENT MATERIALS TECHNOLOGY: EXPANSIONS, JANUARY 2021–JUNE 2025 405
TABLE 424 ELEMENT MATERIALS TECHNOLOGY: OTHER DEVELOPMENTS,
JANUARY 2021–JUNE 2025 406
TABLE 425 PACE ANALYTICAL SERVICES: COMPANY OVERVIEW 407
TABLE 426 PACE ANALYTICAL SERVICES: SERVICES OFFERED 407
TABLE 427 PACE ANALYTICAL SERVICES: DEALS, JANUARY 2021–JUNE 2025 409
TABLE 428 PACE ANALYTICAL SERVICES: EXPANSIONS, JANUARY 2021–JUNE 2025 411
TABLE 429 ALMAC GROUP: COMPANY OVERVIEW 412
TABLE 430 ALMAC GROUP: SERVICES OFFERED 412
TABLE 431 ALMAC GROUP: SERVICE APPROVALS, JANUARY 2021–JUNE 2025 413
TABLE 432 ALMAC GROUP: DEALS, JANUARY 2021–JUNE 2025 413
TABLE 433 ALMAC GROUP: EXPANSIONS, JANUARY 2021–JUNE 2025 413
TABLE 434 PHARMARON BEIJING CO., LTD.: COMPANY OVERVIEW 415
TABLE 435 PHARMARON BEIJING CO., LTD.: SERVICES OFFERED 415
TABLE 436 PHARMARON BEIJING CO., LTD.: DEALS, JANUARY 2021–JUNE 2025 416
TABLE 437 SYNEOS HEALTH: COMPANY OVERVIEW 417
TABLE 438 PAREXEL INTERNATIONAL (MA) CORPORATION: COMPANY OVERVIEW 418
TABLE 439 LGC LIMITED: COMPANY OVERVIEW 419
TABLE 440 CELERION: COMPANY OVERVIEW 420
TABLE 441 BIOAGILYTIX: COMPANY OVERVIEW 421
TABLE 442 ALCAMI CORPORATION: COMPANY OVERVIEW 422
TABLE 443 SAMSUNG BIOLOGICS: COMPANY OVERVIEW 423
TABLE 444 CURIA GLOBAL, INC.: COMPANY OVERVIEW 424
TABLE 445 BA SCIENCES: COMPANY OVERVIEW 425
TABLE 446 AVANCE BIOSCIENCES: COMPANY OVERVIEW 426
LIST OF FIGURES
FIGURE 1 MARKET & GEOGRAPHIC SEGMENTATION 39
FIGURE 2 REGIONAL SEGMENTATION 40
FIGURE 3 HEALTHCARE ANALYTICAL TESTING MARKET: RESEARCH METHODOLOGY 44
FIGURE 4 RESEARCH DESIGN 45
FIGURE 5 BREAKDOWN OF PRIMARY INTERVIEWS: SUPPLY-SIDE AND DEMAND-SIDE PARTICIPANTS 49
FIGURE 6 BREAKDOWN OF PRIMARY INTERVIEWS: BY COMPANY TYPE, DESIGNATION,
AND REGION 50
FIGURE 7 RESEARCH METHODOLOGY: HYPOTHESIS BUILDING 51
FIGURE 8 MARKET SIZE ESTIMATION: REVENUE SHARE ANALYSIS 52
FIGURE 9 REVENUE SHARE ANALYSIS: COMPANY ILLUSTRATION 53
FIGURE 10 TOP-DOWN APPROACH 53
FIGURE 11 CAGR PROJECTIONS FROM ANALYSIS OF DRIVERS, RESTRAINTS, OPPORTUNITIES, AND CHALLENGES 55
FIGURE 12 HEALTHCARE ANALYTICAL TESTING SERVICES MARKET: CAGR PROJECTIONS, 2025─2030 56
FIGURE 13 DATA TRIANGULATION METHODOLOGY 58
FIGURE 14 HEALTHCARE ANALYTICAL TESTING SERVICES MARKET, BY TYPE,
2025 VS. 2030 (USD MILLION) 61
FIGURE 15 BIOANALYTICAL TESTING SERVICES MARKET, BY TYPE,
2025 VS. 2030 (USD MILLION) 62
FIGURE 16 PHYSICAL CHARACTERIZATION TESTING SERVICES MARKET,
BY TYPE, 2025 VS. 2030 (USD MILLION) 63
FIGURE 17 HEALTHCARE ANALYTICAL TESTING SERVICES MARKET, BY END USER,
2025 VS. 2030 (USD MILLION) 64
FIGURE 18 GEOGRAPHIC SNAPSHOT OF HEALTHCARE ANALYTICAL TESTING SERVICES MARKET 65
FIGURE 19 RISING NUMBER OF CLINICAL TRIALS AND GROWING OUTSOURCING OF PHARMA R&D SERVICES TO CROS TO PROPEL MARKET 66
FIGURE 20 BIOANALYTICAL TESTING SERVICES SEGMENT ACCOUNTED FOR LARGEST MARKET SHARE IN GERMANY IN 2O24 67
FIGURE 21 CHINA TO REGISTER HIGHEST GROWTH RATE DURING FORECAST PERIOD 68
FIGURE 22 NORTH AMERICA REGION TO DOMINATE MARKET DURING FORECAST PERIOD 69
FIGURE 23 HEALTHCARE ANALYTICAL TESTING SERVICES MARKET: DRIVERS, RESTRAINTS, OPPORTUNITIES, AND CHALLENGES 70
FIGURE 24 INCREASING NUMBER OF CLINICAL TRIALS WORLDWIDE (2004–2024) 74
FIGURE 25 PERCENTAGE OF REGISTERED STUDIES BY LOCATION (AS OF 2024) 74
FIGURE 26 PHARMACEUTICAL & BIOPHARMACEUTICAL R&D EXPENDITURE, 2002–2024 75
FIGURE 27 HEALTHCARE ANALYTICAL TESTING SERVICES MARKET: ECOSYSTEM ANALYSIS 81
FIGURE 28 HEALTHCARE ANALYTICAL TESTING SERVICES MARKET: VALUE CHAIN ANALYSIS 89
FIGURE 29 HEALTHCARE ANALYTICAL TESTING SERVICES MARKET: PORTER’S FIVE FORCES ANALYSIS 91
FIGURE 30 INFLUENCE OF STAKEHOLDERS ON BUYING PROCESS FOR HEALTHCARE ANALYTICAL TESTING SERVICES 93
FIGURE 31 KEY BUYING CRITERIA FOR HEALTHCARE ANALYTICAL TESTING SERVICES,
BY END USER 94
FIGURE 32 REVENUE SHIFT IN HEALTHCARE ANALYTICAL TESTING SERVICES MARKET 99
FIGURE 33 HEALTHCARE ANALYTICAL TESTING SERVICES MARKET: NUMBER OF DEALS,
BY KEY PLAYER, 2019–2023 (USD MILLION) 100
FIGURE 34 HEALTHCARE ANALYTICAL TESTING SERVICES MARKET: NUMBER OF INVESTOR DEALS, BY KEY PLAYER, 2019–2023 (USD MILLION) 100
FIGURE 35 VALUE OF INVESTOR DEALS IN HEALTHCARE ANALYTICAL TESTING SERVICES MARKET, BY KEY PLAYER, 2019–2023 (USD MILLION) 101
FIGURE 36 USE OF GEN AI ON HEALTHCARE ANALYTICAL TESTING SERVICES MARKET 103
FIGURE 37 NORTH AMERICA: HEALTHCARE ANALYTICAL TESTING SERVICES MARKET 177
FIGURE 38 ASIA PACIFIC: HEALTHCARE ANALYTICS TESTING SERVICES MARKET SNAPSHOT 237
FIGURE 39 REVENUE ANALYSIS OF KEY PLAYERS IN HEALTHCARE ANALYTICAL TESTING SERVICES MARKET, 2020−2024 313
FIGURE 40 MARKET SHARE ANALYSIS OF KEY PLAYERS IN HEALTHCARE ANALYTICAL TESTING SERVICES MARKET (2024) 314
FIGURE 41 HEALTHCARE ANALYTICAL TESTING SERVICES MARKET: COMPANY EVALUATION MATRIX (KEY PLAYERS), 2024 317
FIGURE 42 HEALTHCARE ANALYTICAL TESTING SERVICES MARKET: COMPANY FOOTPRINT 318
FIGURE 43 HEALTHCARE ANALYTICAL TESTING SERVICES MARKET: COMPANY EVALUATION MATRIX (STARTUPS/SMES), 2024 323
FIGURE 44 EV/EBITDA OF KEY VENDORS 327
FIGURE 45 YEAR-TO-DATE (YTD) PRICE TOTAL RETURN AND 5-YEAR STOCK BETA OF KEY VENDORS 327
FIGURE 46 HEALTHCARE ANALYTICAL TESTING SERVICES MARKET: BRAND/SERVICE COMPARATIVE ANALYSIS 328
FIGURE 47 EUROFINS SCIENTIFIC SE: COMPANY SNAPSHOT (2024) 334
FIGURE 48 LABCORP HOLDINGS INC.: COMPANY SNAPSHOT (2024) 340
FIGURE 49 INTERTEK GROUP PLC: COMPANY SNAPSHOT (2024) 345
FIGURE 50 ICON PLC: COMPANY SNAPSHOT (2024) 351
FIGURE 51 IQVIA INC.: COMPANY SNAPSHOT (2024) 356
FIGURE 52 WUXI APPTEC CO., LTD.: COMPANY SNAPSHOT (2024) 360
FIGURE 53 CHARLES RIVER LABORATORIES: COMPANY SNAPSHOT (2024) 364
FIGURE 54 SGS SA: COMPANY SNAPSHOT (2024) 369
FIGURE 55 THERMO FISHER SCIENTIFIC INC.: COMPANY SNAPSHOT (2024) 375
FIGURE 56 MEDPACE HOLDINGS, INC.: COMPANY SNAPSHOT (2024) 379
FIGURE 57 SARTORIUS AG: COMPANY SNAPSHOT (2024) 382
FIGURE 58 MERCK KGAA: COMPANY SNAPSHOT (2024) 385
FIGURE 59 ALS: COMPANY SNAPSHOT (2024) 393
FIGURE 60 FRONTAGE LABORATORIES, INC.: COMPANY SNAPSHOT (2024) 396
FIGURE 61 STERIS PLC: COMPANY SNAPSHOT (2024) 400
MarketsandMarkets（マーケッツアンドマーケッツ）は世界中の企業に高い評価を得ており、著名メディアでの引用頻度も高い、インドの最大手級の市場調査会社です。広範な市場を対象にした市場調査レポートを出版しています。
※MarketsandMarketsの調査レポートはほぼ全タイトルご注文後、最短3時間～12時間以内（営業日基準）にご納品可能です。
ライセンス別価格表
調査会社の事情により予告なしに変更されることがございます。最新の状況およびその他のパターンについてはお問い合わせください。
ライセンスタイプ1
| シングルユーザ | マルチユーザ | コーポレート | エンタープライズサイト |
| USD4,950 | USD6,650 | USD8,150 | USD10,000 |
ライセンスタイプ2
| シングルユーザ | マルチユーザ | コーポレート | エンタープライズサイト |
| USD7,150 | USD8,500 | USD9,650 | USD11,000 |
ライセンスタイプ3
| シングルユーザ | マルチユーザ | コーポレート | エンタープライズサイト |
| USD8,150 | お問合せください | お問合せください | お問合せください |
ライセンスタイプ4
| シングルユーザ | マルチユーザ | コーポレート | エンタープライズサイト |
| USD9,000 | USD10,500 | USD12,000 | USD13,500 |
ミニレポート ※定性調査にフォーカスした調査レポートです。詳細はお問合せください。
| シングルユーザ | コーポレート |
| USD 2,650 | USD 4,250 |
ご購入に関するご案内
価格・納期について
- 価格
- ウェブサイトに記載の外貨（定価）を見積日のTTSレートで換算後消費税を加えた金額が弊社からの請求金額になります。見積金額はレート変動に関係なく見積書発行日より2週間有効です。手数料（ハンドリングチャージ）無料。
- ライセンス
- シングルユーザライセンス
- 1名のみレポートファイルのご利用が可能です。
- マルチユーザライセンス
- 同一企業内（関連会社除く）5名までレポートファイルのご利用が可能です。
- コーポレートライセンス
- 同一企業および100％持株会社間・人数無制限でレポートファイルのご利用が可能です。
- エンタープライズサイトライセンス
- 特別ライセンスです。適用範囲についてはお問合せください。
- シングルユーザライセンス
- 納品形態
- Eメール
- 納期
- 最短3時間以内にご納品可能です。通常ご注文後24時間以内（営業日基準）
ご注文方法
- レポートページ内のお問い合わせフォームより見積もりをご請求ください。確認次第見積書と発注書をお送りいたします。既に弊社の見積書をお持ちの場合にはEメールまたはFAXでご注文ください。
その他
- 商品の性質上、ご注文後のキャンセル/返品/交換はできません。ご了承ください。
株式会社SEMABIZはMarketsandMarketsの日本に拠点をおく販売代理店として、MarketsandMarketsのレポートを販売しております。サンプルページのご依頼、見積り、レポートに関するご質問など購入前のご相談はいつでもお気軽にご連絡ください。
最新調査レポート
- 自動車用アラミド繊維市場規模、シェア、動向、2030年までの世界予測 2025-12-15
- ポリヒドロキシアルカノエート (PHA) 市場規模、シェア、動向、2030年までの世界予測 2025-12-15
- 複合輸送市場規模、シェア、動向、2032年までの世界予測 2025-12-12
- 有機酸市場規模、シェア、動向、2030年までの世界予測 2025-12-11
- ハイブリッドボンディング市場規模、シェア、動向、2032年までの世界予測 2025-12-11